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Intracranial empyema is a rare neurological emergency that requires rapid and aggressive intervention. This case series aims to describe the clinical presentation, advanced imaging findings, and short and long term outcomes in dogs with intracranial empyema.
Medical records from two referral hospitals were searched and identified dogs diagnosed with intracranial empyema. Inclusion criteria comprised of an MRI consistent with contiguous infection from adjacent structures, a CSF analysis suggestive of empyema or direct visualization of purulent material during intracranial surgery.
Ten dogs were included, with a median age of 2 years (range 4 months-12.5 years). All presented as emergencies with 8/10 showing neurological abnormalities and 2/10 with retrobulbar swelling and exophthalmos. 6/10 had surgical intervention, 2/10 were medically managed and the remaining 2/10 were euthanised. Typical MRI findings included extra-axial, T1-weighted hypo-isointense, T2-weighted hyperintense material with varying degrees of contrast enhancement, with 6/9 showing evidence of contiguous infection from adjacent structures on MRI. 6/10 had culture and sensitivity performed with 2/6 returning Enterococcus and Streptococcus species respectively. The median antimicrobial course length was 6 weeks (range 2-28 weeks). 8/10 survived to discharge, with a median hospitalisation time of 6.5 days (range 4-10 days). 5/8 are still alive at the time of writing (1 lost to follow up; 2 euthanised for other reasons) with all five considered neurologically normal with a successful long term outcome.
Whilst intracranial empyema in dogs is a rare condition, excellent outcomes are possible in those cases treated appropriately. SeSAME (Seizures, Sensorineural deafness, Ataxia, Mental retardation, and Electrolyte imbalance) or EAST (Epilepsy, Ataxia, Sensorineural deafness, Tubulopathy) syndrome is a multisystemic disorder in man. The condition is exclusively caused by homozygous or compound heterozygous variations in the KCNJ10 gene. Here we describe a similar syndrome in the Malinois dog breed. This mutation differs from the already identified KCNJ10 mutation in the Russell group of terriers responsible for spinocerebellar ataxia with myokymia, seizures, or both.
Four 4-month-old Malinois of 2 unrelated families were presented for an uncoordinated gait since the age of 12 weeks. Neurological examination revealed severe generalized hypermetric ataxia in all dogs, involuntary vermicular muscle twitching (myokymia) triggered by excitement in 2 dogs and epilepsy in 2 dogs. Absent patellar reflexes were noted in all dogs. Complete blood count, serum biochemistry, urinalysis, magnetic resonance imaging of the brain and CSF analysis did not reveal any abnormalities. Electromyography showed neuromyotonic discharges in the clinically affected muscles. Results of motor nerve conduction and repetitive nerve stimulation did not differ from two age-matched Malinois control dogs, however, brainstem auditory evoked potentials showed disappearance of wave components and mildly prolonged latencies in the affected dogs. Histopathology revealed bilateral myelopathy with predominant axonopathy and myelin vacuolization in the central nervous system. Genetic analysis detected a novel pathogenic KCNJ10 c.986T>C (p.Leu329Pro) variant, which is inherited in an autosomal recessive way.
Conclusively, these mutant Malinois dogs may serve as a promising animal model to elucidate the pathogenesis and treatment of this disorder in man. Inherited juvenile-onset polyneuropathy with laryngeal paralysis has been reported in several breeds of dogs such as Dalmatian, Alaskan Malamute, Leonberger, Russian Black terrier, Rottweiler and Pyrenean mountain dogs, with a suspected autosomal recessive inheritance pattern.
JUVENILE
Eight young American Staffordshire Terriers were presented for inspiratory stridor and dyspnoea (7/8), locomotor weakness (8/8) with palmigrade and plantigrade stance (5/8), with an age of onset ranged from two to six months. Neurological evaluation revealed four limbs ataxia with high stepping pelvic limb gait (8/8), limb muscles atrophy (6/8), cutaneous hypoesthesia (5/8) and decreased spinal reflexes (5/8).
Laryngeal paralysis was diagnosed during laryngoscopy in seven dogs. Electrophysiological investigations showed abnormal spontaneous electrical activities in the laryngeal muscles (7/8) and appendicular muscles (8/8), marked attenuation of compound muscle action potentials amplitude (8/8), reduced motor nerve conduction velocities (7/8), decreased or absent sensory nerve action potentials (8/8).
Muscle biopsies were performed in six cases and histologic analysis was consistent with neurogenic atrophy and intramuscular nerve branches myelinated fiber loss. Fibular nerve biopsy analysis, when performed (four cases), was consistent with chronic and severe extensive nerve fiber loss resulting from axonal degeneration.
To the authors' knowledge, this is the first report of a juvenileonset polyneuropathy with laryngeal paralysis in American Staffordshire Terrier. One of the dogs is a backcross and an autosomal recessive mode of inheritance is suspected. If pedigree analysis and genotyping are consistent with this hypothesis, the American Staffordshire Terrier polyneuropathy could be considered as a new spontaneous animal model of inherited axonal neuropathy (Charcot-Marie-Tooth disease). Genotyping could lead to the discovery of new genes involved in axonal degeneration. Tissue mechanical properties vary over several orders of magnitude in the disease state and elude current veterinary neuroimaging modalities. Magnetic Resonance Elastography (MRE) combines conventional MRI with acoustic wave propagation to generate high-resolution viscoelasticity or 'stiffness' data and is emerging as a valuable, non-invasive diagnostic tool in human neurology. The purpose of this study was to establish whether MRE could be applied to the canine brain.
MAGNETIC RESONANCE ELASTOGRAPHY -TOWARDS
Post-mortem brain scans were performed on canines euthanized on welfare grounds with approval of the R(D)SVS Veterinary Ethical Review Committee. A standard cartesian Echo Planar Imaging sequence with additional motion encoding gradients was used for multiple frequency (30-100 Hz) acquisition on a 3T Verio MRI system (Siemens Medical Systems), with vibrations generated by the Resoundant actuator and head pillow (http://resoundant.com/). Raw phase images were analysed with the Elastography Software Pipeline to produce maps of viscoelastic parameters.
Our protocol readily propagated waves into the specimens enabling construction of high-resolution elastograms of the canine brain. Variation in tissue stiffness across different brain regions was observed, as noted in the human brain in vivo. Mean whole brain tissue viscoelasticity AE standard error was 2.99 AE 0.30 kPa (n = 3). This is the first demonstration that acoustic waves can be propagated into the canine brain in situ. Our follow-on objective is to construct a reference atlas of canine brain stiffness against which to test the sensitivity of MRE for detecting and differentiating agerelated and pathological changes. 'Virtual palpation' of the brain with MRE has the potential to revolutionize veterinary neuroimaging. Brain damage causes profound and prolonged ATP loss. Prior in vitro studies showed that supplementation of ischaemic brain slices with precursors of ATP synthesis, D-ribose&Adenine (RibAde), restores ATP levels. We aimed to assess the therapeutic potential of RibAde AE Allopurinol in a rat model of transient focal cerebral ischaemia. Allopurinol should potentiate the effect of RibAde by preserving hypoxanthine, also used in the purine salvage pathway.
This study conforms to the UK Animals (Scientific Procedures) Act. Male Wistar rats were randomised to three groups and the investigator was blinded to treatment. After 1-h transient focal ischaemia, RibAde group received at reperfusion an intravenous infusion of ribose (200 mg/kg/h) and adenine (10 mg/kg/h) over 6 h. RibAde&Allopurinol group also received allopurinol (10 mg/ kg, IP). Saline group received intravenous and intraperitoneal injections of saline. Acute ischaemic injury and subsequent infarction were assessed by MRI immediately prior to reperfusion (diffusion weighted imaging) and 7 days after reperfusion (T2-weighted imaging). Functional outcome was assessed at days 1, 3 and 7 post-stroke.
RibAde AE Allopurinol had no significant side-effect. A greatest reduction in lesion volume between day 0 and day 7 was observed in the RibAde AE Allopurinol (50 % reduction, n = 8) and RibAde groups (38 %, n = 8) compared to Saline group (18 %, n = 6). This did not achieve statistical significance but was accompanied by a trend for faster functional recovery.
This pilot study suggests RibAde&Allopurinol as a potential therapy for stroke. Larger studies are required for confirmation of these preliminary results, before translation as a therapeutic option in clinical settings. Intervertebral disc extrusion (IVDE) is a common cause of severe spinal cord injury, and an accurate prognosis remains challenging. Hemorrhage in the spinal cord or in the subarachnoidal space may have an important impact on damage of the spinal cord parenchyma and outcome, and thus, may be relevant for the prognosis of dogs with IVDE. Therefore, the aim of the study was to evaluate if blood degradation products and ferritin are measurable in the CSF of dogs with thoracolumbar IVDE, and if there is an association to clinical parameters.
ANALYSIS OF BLOOD DEGRADATION PRODUCTS AND
Measurements of net oxyhemoglobin absorption (NOA), net bilirubin absorption (NBA) and ferritin concentration were prospectively performed in the CSF of 34 dogs with thoracolumbar IVDE, 21 dogs with idiopathic epilepsy either native (IE) or artificially contaminated with blood (IEc), and 9 dogs with steroid responsive meningitis arteritis (SRMA).
The NOA was significantly higher in the IVDE group compared to the IE (P < 0.001) and SRMA (P < 0.001), but not to the IEc group (P = 0.89). The NBA was significantly higher in the IVDE group compared to all control groups (P < 0.001, respectively). Ferritin concentration was significantly higher in the IVDE compared to the IE group (P = 0.03). In dogs with IVDE, there was no association between NOA, NBA and ferritin concentration and severity and duration of clinical signs, and outcome.
It is possible to quantify blood degradation products and ferritin in the CSF. However, larger case numbers are needed to evaluate their relevance as prognostic indicator in dogs with thoracolumbar IVDE.
THE ODDS OF DEMOGRAPHIC, SOCIAL AND ENVIRON-MENTAL FACTORS INFLUENCING THE DEVELOPMENT OF ACUTE CANINE POLYRADICULONEURITIS IN THE
UK. E. J. Laws, T. R. Harcourt-Brown, N. Granger, J. H. Rose. University of Bristol, Bristol, UK Immune-mediated diseases, in animals and man, have been linked to factors and triggers that contribute to the pathogenesis of disease. The aim of this study was to identify if the development of acute canine polyradiculoneuritis (ACPRN) is associated with recent vaccination, breed, season, rural/urban habitation, sex, neuter status or age.
A retrospective case-control study with conditional logistic regression analysis was performed. Dogs were selected from a referral hospital population in the UK and controls were matched for year of presentation.
Forty-three cases were identified with ACPRN and 86 controls were selected. Jack Russell Terriers (P = 0.003) and West-Highland White Terriers (P = 0.021) were found to have a significantly greater odds of developing ACPRN compared to 'other breeds' in our population of dogs. The odds of developing ACPRN were greater in the autumn (P = 0.043) and winter (P = 0.032) compared to spring. Vaccination, rural/urban habitation, sex, neuter status and age were not found to increase the odds of developing ACPRN.
In conclusion breed and season were found to increase the odds of developing ACPRN. This may be important in further understanding the pathogenesis of disease. This may allow identification of triggers or genetics that play a role in ACPRN and allow us to develop breeding programs, avoid triggers or even produce preventative treatments to reduce the prevalence of the disease.
ACCURACY OF A PATIENT-SPECIFIC 3D-PRINTED DRILL GUIDE FOR VERTEBRAL PEDICLE SCREW PLACEMENT. S. Bennett, S. Behr, B. Oxley. Department of Neurology and Neurosurgery, Willows Referral Service, Solihull, England
The aim of this study was to develop a patient-specific 3D-printed drill guide for placement of caudal cervical bicortical pedicle screws as part of the treatment of disc-associated wobbler syndrome and to validate its accuracy.
CT scans of the cervical vertebrae from two patients were acquired. These data were exported to medical image processing software and virtual 3D models of the vertebrae created for processing in computer aided design (CAD) software. This was used to determine the optimal trajectory and size of the pedicle screws. For each patient virtual drill guides were created, 3D-printed, and used intraoperatively. Locking titanium screws were used to reduce metal artifact on post-operative CT; screw heads were bonded with polymethylmethacrylate cement to stabilise affected vertebral segments. Post-operative CT was performed for each patient; the degree of vertebral canal violation was subsequently graded as 0 (no violation), 1 (<2 mm), 2 (2-4 mm) and 3 (>4 mm). For each screw CAD files were analysed to yield a screw-diameter-topedicle-width-ratio (SDPWR) at the narrowest point of the pedicle; this was expressed as a percentage.
A total of 22 screws were placed; 11 screws were 3.5 mm, nine were 2.7 mm and two were 2.4 mm. 20 screws (90.9%) were grade 0, 2 (9.1%) were grade 1 and no screws were grade 2 or 3. This was achieved despite a mean SDPWR of 73.6 % (range 57.9-93.3%).
The use of a 3D-printed patient-specific drill guide permitted accurate placement of bicortical pedicle screws in the caudal cervical vertebrae. This technique has the potential to improve clinical outcome through increased osteosynthesis strength, reduced surgical time and reduced morbidity. UVet, The University of Melbourne, Victoria, Australia Feline infectious peritonitis (FIP) is the most common infectious central nervous system disease in the cat, and is invariably fatal. Improved means of ante mortem diagnosis are required to facilitate clinical decision-making. Information regarding the magnetic resonance imaging (MRI) findings in cases of FIP is currently limited, resulting in the need for better descriptions to optimize the use of this imaging modality as a diagnostic tool in suspected cases.
CLINICAL FEATURES AND MAGNETIC RESONANCE
The aim of this study was to describe the MRI findings in cases of confirmed neurological FIP. Archived records from 4 institutions were retrospectively reviewed to identify cases with confirmed neurological FIP that had undergone MRI of the brain and/or spinal cord. Signalment, clinical, clinicopathological, histopathological findings and outcome were evaluated.
MRI abnormalities were detected in all 20 cases, including periventricular contrast enhancement (17), leptomeningeal contrast enhancement (18), ventriculomegaly (17), syringomyelia (14) and foramen magnum herniation (12). CSF was analysed in 10 cases, all of which demonstrated a marked increase in both total protein and total nucleated cell count.
All 20 cases were euthanized due to the grave prognosis. The median survival time from onset of clinical signs to euthanasia was 14 days (range 2-105).
Histopathological analysis revealed perivascular pyogranulomatous and/or lymphoplasmacytic infiltrates affecting the leptomeninges in 13 cases, the choroid plexus in 13 cases, periventricular infiltrates in 11, the spinal cord parenchyma in 7 and the brain parenchyma in 3.
MRI provides a sensitive means of detecting neurological FIP, particularly in combination with consistent signalment, clinical presentation and CSF analysis. Despite being a common diagnosed disease in veterinary neurology, treatment options in literature for m eningo-encephalo-myelitis of unknown origin are quite variable and poorly standardised. The use of Cytarabine Arabinoside (CA) (50 mg/m 2 at repeated injections) in combination with prednisolone has been previously reported with variable success rates. The aim of the paper was to determine the efficiency and safety of high dosage CA (100 mg/ m 2 ) protocol in conjunction with prednisolone and the outcome for dogs according to previously reported variables. These were assessed through a repeated cerebrospinal fluid collection obtained around the 6 th CA administration (average -3, 4 months) after the initiation of protocol, records of survival, relapse rates and side effects.
SAFETY AND EFFICIENCY OF AN
The Chihuahua appeared statistically over-represented in this study in regard to our regular hospital population. Eighty seven percent of dogs (77/89) were alive by the completion of the protocol, 81% were considered to have a positive outcome and 46% of dogs did not require any further CA administration. Thirty percent of dogs (27/89) relapsed during the protocol period and 15% after its completion. Cerebrospinal fluid analysis did not allow to predict relapse in this study. Dogs with a forebrain lesions and a higher initial dose of glucocorticoids had increased odds of a positive outcome. Brainstem lesions appear to carry a worse outcome. The degree of pleocytosis and protein contents at the first CSF collection was not a prognostic factor of outcome.
This (100 mg/m 2 SQ for 48 h every 3 weeks, 6 times) protocol of CA appears safe and enabled to reduce faster the initial immumusuppressive dosage of prednisolone with lower risks of heavy side effects and a better short term outcome. A multitude of factors must be overcome following spinal cord injury. Chondroitin sulphate proteoglycans (CSPGs) of the glial scar present a significant block to axonal regeneration. Digestion of CSPGs by the bacterial enzyme chondroitinase ABC (ChABC) leads to axonal regeneration, neuronal plasticity and functional improvement in rodent spinal cord injury models. However, the enzyme degrades within 24-72 h at body temperature, limiting its application. Another therapy for spinal cord repair, the olfactory ensheathing cell (OEC) transplant, has been shown to be beneficial in numerous rodent spinal cord injury paradigms and in naturally occurring spinal cord injury in canine patients. OECs support and guide axonal regeneration across the lesion gap. We have genetically modified canine OECs to produce a mammalian ChABC using a lentiviral vector thereby combining these two promising therapies.
GENETICALLY
We have demonstrated digestion of CSPGs with OECs expressing ChABC in vitro using an enzyme assay and western blotting. In nude rats with dorsal column crush injury, we also observed digestion of CSPGs following transplantation of OECs expressing ChABC. To improve the safety and clinical applicability of the system, we have developed a tetracycline regulated lentiviral vector (Tet-On) capable of switching ChABC production 'on' when oral doxycycline is given to the animal. We have achieved efficient lentiviral transduction of neurons and regulatable digestion of CSPGs in vitro and in vivo with the addition or removal of doxycycline.
In conclusion, we have generated a novel cell therapy that we plan to develop further using dogs with naturally occurring spinal cord injury. Only 35% of Cavalier King Charles Spaniels (CKCS) with syringomyelia display pain-associated behaviours, but we suspect that a greater proportion experience pain. An objective means of detecting pain in these dogs is lacking. Electronic von Frey aesthesiometer (eVF) testing consists of applying pressure onto the skin via a plastic tip. The pressure value is displayed electronically. Exceeding a certain pressure, defined as the skin sensitivity threshold, triggers a behavioural response from the dog.
UTILITY OF THE ELECTRONIC
We conducted an ethically-approved, two-centre prospective observational study to assess whether the eVF could differentiate, based on cervical skin sensitivity threshold, CKCS with: (i) syringomyelia and clinical signs (syringomyelia-symptomatic -SM-S); (ii) syringomyelia without clinical signs (syringomyelia-asymptomatic -SM-A); and (iii) no syringomyelia (syringomyelia-free -SM-F). All dogs had cervical and caudal fossa magnetic resonance imaging.
Following acclimatisation, the eVF was applied by an investigator blinded to the eVF display and skin sensitivity threshold recorded at C2 and C4 vertebrae bilaterally (three measures per site) and at the right dorsal metatarsal (RH). Data were analysed with multiple analysis of variance including fixed factors (centre, medication, group) and covariates (RH, age, clinical signs duration).
Seventy CKCS were recruited into: SM-S (37), SM-A (15), . No difference in sensitivity was found between groups, except for the RH when analysed as a covariate (P = 0.031) but not post-hoc as a dependent variable (P = 0.885). Split plot analysis of variance demonstrated differences between cervical sites, independently of syringomyelia group (P < 0.001).
In conclusion, eVF assessment of skin sensitivity does not differ significantly by syringomyelia status. To fill this gap, we recorded the gait of 10 DM dogs with 3D motion capture technology during treadmill locomotion and quantified pelvic/thoracic limb coordination in each inter-girdle pair of limbs (described as right and left diagonal coupling intervals) and pelvic limb lateral stability. We compared these to 15 neurologically healthy controls and 10 dogs diagnosed with intervertebral disc herniation. Dogs were diagnosed with MRI and tested for SOD1 mutation. We also sequenced C9orf72, TARDBP, FUS, and VCP genes linked to human ALS. One DM dog was negative for the SOD1 mutation but bore a FUS mutation.
KINEMATIC MEASURES FOR ASSESSING GAIT IN DOGS
Marked kinematic differences were revealed between DM and control dogs for pelvic/thoracic limb coordination (P < 0.001) and pelvic limb lateral stability (P = 0.015). Dogs with DM had significantly greater difference between right and left diagonal coupling intervals (P = 0.046) compared to disc cases. This supported the known clinical finding that DM dogs are usually asymmetrically affected during the course of their disease. These preliminary data altogether provide baseline kinematic measures for DM dogs that might serve as a benchmark for future studies. Canine degenerative myelopathy (DM) is a progressive neurological disorder associated with a 118G>A mutation of the SOD1 gene and is inherited in an autosomal recessive manner. The impact of this mutation on the dynamics of the wild type and mutant forms of the SOD1 proteins is largely unknown. Here we investigated the steady state levels of the SOD1 in the thoracic spinal cord of homozygotes. The cellular behaviour of SOD1 proteins was explored using an in vitro transfection system to track the distribution of wild type and mutant SOD1 fusion proteins containing either a Cherry or EGFP fluorescent tag.
CANINE DEGENERATIVE MYELOPATHY ASSOCIATED
We report that the spinal cord level of SOD1 is significantly reduced in DM and SOD1 solubility properties are altered. The in vitro studies confirmed the fusion proteins had enzymatic activity using a native gel system. SOD1 aggregates accumulate in cells expressing mutant but not wild type Sod1 cDNA recombinants. Wild type and mutant fusion proteins with different fluorescent tags co-localise in co-transfectants suggesting a direct interaction and also form aggregates.
This study suggests that the Sod1 mutation affects the turnover dynamics of SOD1 and aggregate formation in vitro. Evidence for a direct association between wild type and the DM mutant forms of SOD1 together with aggregate formation suggests a potential for a toxic mechanisms in the heterozygous scenario. This experimental paradigm will assist in identifying the mechanisms affecting SOD1 dynamics and explain why heterozygotes, in general, do not develop DM.
Ethical approval was granted for the collection of tissue. Equine motor neuron disease (EMND), a degenerative polyneuropathy, is characterised by an insidious onset of generalised muscle atrophy, and mild elevations in plasma muscle enzyme activities. Affected horses are paretic and present with an 'elephant on a drum' stance and intermittent muscle fasciculation. Antemortem, gold standard diagnosis is achieved by biopsy of the sacrocaudalis dorsalis muscle.
In this study, we hypothesised that these classic clinical signs are a manifestation of various neuromuscular problems, rather than being specific for EMND. We retrospectively examined muscle biopsy submissions from horses with suspected EMND and compared them with the final diagnosis.
Of a total of 85 biopsy samples from horses with possible EMND, 24 had neuropathic histological features, of which EMND was diagnosed in 18 (21%). 28 (33%) had various myopathic features, of which 9 (11%) had polysaccharide storage myopathy (PSSM). 24 (28%) biopsy submissions were considered normal and 9 (11%) had an open diagnosis. Of the 9 PSSM cases, 3 were homozygous for the R309H GYS1 mutation responsible for PSSM1, 2 were heterozygotes, 1 was wild type and therefore diagnosed with PSSM2. Genotyping was unavailable for the remaining 3.
This study reveals the high prevalence of primary myopathies in horses suspected to have EMND, in particular of PSSM. It emphasizes the need for additional testing, because the final result would likely influence prognosis and disease management. Canine cognitive dysfunction (CCD) or "canine dementia" is a neurobehavioural syndrome in aged dogs characterized by varying degree of progressive cognitive decline and with certain similarities to the clinical and neuropathological changes associated with Alzheimer's disease (AD) in humans.
The present study investigated specific markers of brain pathology related to aging and cognitive dysfunction in dogs and compared these findings to human AD neuropathology. The neuropathological investigations included evaluation of amyloid-b (Ab) plaque deposition (including N-terminally truncated and pyroglutamyl-modified Ab) and tau pathology in the prefrontal cortex from fifteen aged dogs with normal cognitive function, mild cognitive impairment or CCD and compared with findings in the prefrontal cortex from two young control dogs and sections from human AD subjects.
Cortical Ab deposition was found to be only of the diffuse subtype as no dense-core or neuritic plaques were found. The Ab deposition followed a progressive pattern in four maturation stages. Accumulation of the Ab peptide was also extensively observed in the vessel walls. Both immunohistochemically and biochemically measured levels of Ab pathology in the prefrontal cortex showed a consistent positive correlation to age but not to cognitive decline. No evidence of neurofibrillary tau pathology was found.
In conclusion, the findings support the senescent dog with spontaneous cognitive dysfunction as a valuable non-transgenic model for further investigations of the molecular events involved in the neurodegenerative processes associated with aging and early stage AD, especially the Ab-related pathology. Compounds for status epilepticus (SE) have exclusively been developed from drugs for chronic therapy. With 20-40% mortality for SE in both people and dogs, there is a need to develop novel drugs with unique properties. The purpose of these studies have been to validate the canine model of SE via RCTs, and to utilize 4-6 research dog with naturally occurring epilepsy to initially test compounds.
BIDIRECTIONAL BENEFITS OF A NATURALLY OCCUR-RING CANINE MODEL FOR TESTING AND DEVELOP-MENT OF DRUGS FOR STATUS EPILEPTICUS.
Pharmacokinetic analysis of IV levetiracetam, and IV fosphenytoin was performed in 4-6 research dogs with modeling simulations that led to RCTs for SE of 30-60 mg/kg of IV levetiracetam and 15 mg/kg phenytoin equivalent of fosphenytoin in 19 and 31 client owned dogs respectively. 10-20 mg/kg of a novel formulation of IV topiramate was studied for pharmacokinetic and EEG pharmacodynamic parameters.
The RCT for levetiracetam resulted in a response rate of 56% vs 10% for placebo, and for fosphenytoin of 63% vs 23%. Pharmacokinetic modeling of topiramate indicated that 20 mg/kg IV for dogs not on phenobarbital, and 25-30 mg/kg for dogs on chronic phenobarbital might potentially be effective for SE. EEG analysis during topiramate administration indicated it had similar spectral changes to 0.5 mg/kg IV diazepam. We will be performing similar studies of up to 4 mg/kg IV of allopregnanolone, a novel neurosteroid, over the summer of 2016.
In conclusion, pharmacokinetic and EEG pharmacodynamic testing of established drugs validated the utility of the canine model. In addition, in testing novel IV formulations in the canine model, there is hope for new future therapies of SE for both species. Ambulatory electroencephalography (EEG) is a technique used to diagnose epilepsy in humans. Canine ambulatory EEG involves the application of new wireless, portable video equipment while recording EEG in unsedated dogs. This technology has yet to be evaluated outside the clinical environment. It was hypothesized that recording ambulatory video EEG (vEEG) would be equally achievable in three distinct environments: the intensive care unit (ICU), the neurology examination room, and the home, as measured by physiologic and non-physiologic artifacts. Six healthy dogs were randomized by modified latin square to undergo 2 h vEEG recording in each of the three environments. Twenty minute vEEG epochs (early, middle, and late) were scored in blinded fashion for artifact. Artifact scores were compared for each environment. Instrumental artifact was significantly different between the home kennel and the neurology examination room (P = 0.044) as well as the ICU (P = 0.008). There was no significant difference found between environments for all other artifacts. Based on these findings, three client-owned dogs were instrumented and sent home for ambulatory vEEG recording. The first was accompanied home by the researchers where recording was discontinued after the events of interest occurred. The second and third dogs were sent home in the care of their owners and returned after 24 h of recording. One case was found to have had premature termination of recording before 14 h had elapsed due to drained batteries. This proof of concept study highlights the feasibility of in-home ambulatory vEEG for dogs. Limited information is available regarding the MR imaging characteristics of non-functional sellar masses. The purpose of this study was to determine whether pituitary adenomas can be distinguished from other sellar masses based on MR imaging characteristics since these tumors carry variable prognosis with treatment.
ENVIRONMENT IN CANINE

MAGNETIC RESONANCE (MR) IMAGING CHARACTERIS-TICS OF HISTOPATHOLOGICALLY CONFIRMED NON-FUNCTIONAL SELLAR MASSES IN DOGS.
MR images were retrospectively reviewed for ten histologically confirmed non-functional sellar masses. Histopathology revealed chromophobe pituitary adenomas (n = 4), meningiomas (n = 2), and one each of the following tumor types: pars intermedia adenoma, chromophobe pituitary adenocarcinoma, ependymoma, and craniopharyngioma. All masses were ≥ 2 cm at the largest margin except for 1. All masses were predominately T2 and FLAIR hyperintense with 8/10 masses having some variable intensities within. Both pituitary adenomas and other sellar masses had hemorrhage based on GRE images (7/10). Mild peri-lesional edema was seen with one pituitary adenoma and the pituitary adenocarcinoma. On T1-weighted post-contrast images, all masses were round and discrete and showed moderate to strong contrast enhancement. Bilateral lateral ventricular dilation was seen secondary to one pituitary adenoma and the ependymoma.
Fifty percent of non-functional sellar masses were pituitary adenomas. Pituitary adenomas have similar MR imaging characteristics as other sellar masses. Regardless of histopathology, all sellar masses had a tendency to be large and contained hemorrhage. Sellar masses rarely had concurrent perilesional edema, hydrocephalus, or herniation. The surgical protocol is based on Meij's original work with the addition of a novel telescope and high-definition camera for excellent magnification and illumination of the surgical field. Our pituitary team consists of a surgeon, neurosurgeon and critical care specialist which all play an integral part in each aspect of the patient's care.
WHY, WHEN, HOW AND POST-OPERATIVE CARE OF DOGS UNDERGOING TRANSPHENOIDAL HYPOPHYSEC-
Twenty-two of 34 dogs (65%) evaluated have a P/B ratio of > 0.70 (normal canine P/B ratio < 0.32) with a mean P/B ratio of 0.95. Preliminary results have been very encouraging with some dogs living greater than 2 and 3 years after surgery, either with complete or incomplete resection of their tumor. Those dogs surviving surgery have improvement in their neurologic status and those with hormonally functional tumors show improvement in their hormonal status. Surgical debulking has been followed with radiation therapy in some dogs with promising results. Median long-term survival is currently being investigated.
Our ongoing evaluation has been encouraging for those dogs with large sellar masses and we have had success removing tumors with a P/B ratio of >0.70. The goal of this retrospective study was to examine outcome in dogs with frontal lobe meningiomas undergoing transfrontal craniectomy alone (group 1), surgery and metronomic chemotherapy (group 2) or surgery followed by definitive radiation therapy (group 3). In order to examine the influence of tumor location a control group with temporal, parietal, occipital and cerebellar meningiomas treated with surgery alone was enrolled.
TREATMNENT OF CANINE FRONTAL AND OLFACTORY
Criteria of inclusion were access to complete medical history and information of final outcome. Only dogs discharged from the hospital and free of concurrent disease at the time of diagnosis were included.
Forty dogs with a median age of 9.9 years were enrolled. Seizures (n = 36) were the most frequent clinical sign. Eight dogs were assigned to group 1, 8 to group 2, and 18 to group 3. The control group included 6 dogs. In group 2 CCNU (n = 3) and hydroxyurea (n = 5) was used. The median total radiation dose was 48 gray. Life-threatening perisurgical complications (n = 3) included pneumoencephalus, brain herniation and aspiration pneumonia. Two dogs developed histologically proven radiation necrosis. Four dogs are alive, 15 were euthanized for disease progression and 21 for other reasons. Median survival times were the following; Group 1: 9.5 months, group 2: 14.9 months, group 3: 27.6 months and control group: 30.5 months.
In frontal lobe meningiomas surgery and radiation therapy have the best survival (P = 0.049) similar to non-frontal cases treated with surgery alone, most likely due to the more complete tumor removal in this group. Metronomic chemotherapy does not significantly extend survival time. Mesenchymal stromal cells (MSCs) are able to upload and release drugs. MSCs preloaded by paclitaxel (MSCsPTX) have a strong anti-tumor activity, both in vitro and in vivo, due to their homing capacity towards the tumor and its microenvironment.
PACLITAXEL RELEASING MESENCHYMAL STROMAL
Our study evaluates safety, feasibility and efficacy of MSCsPTX as growth inhibitor of canine gliomas.
After harvesting bone marrow (BM) from dogs and generating BM-MSCsPTX, we evaluated, in vitro, their activity on canine gliomas by means of binding the tumoral cells and their antiangiogenesis activity.
Three dogs with brain gliomas, diagnosed by clinical signs, MRI characteristics and histologic exam, underwent treatment schedule consisting of: day 0-MSCsPTX administrated intrathecally; day 5-temozolomide (100 mg/m² for 5 days every 28 days); day 15-MSCsPTX administrated intravenously. Schedule has been repeated for 5 months. Other three dogs were treated with temozolomide only. All patients had no other treatments. Follow-up included neurologic exam and MRI 3 months after the beginning of treatment.
In vitro results showed a considerable killing activity of BMMSCsPTX; no adverse effects followed BM-MSCsPTX administration. Neurologic exams were normal. MRI showed no further tumor development in the first group.
The results suggest that BM-MSCsPTX may be a safe and feasible optional treatment for canine gliomas. The study purpose was to evaluate a modified transfrontal surgical approach providing greater rostral cerebral and falcine access. Medical records were searched for dogs undergoing transfrontal craniotomy, and data retrieved regarding signalment, surgical procedure, complications, histopathologic diagnosis and outcome. Patients were predominantly large mixed-breed dogs, median age 9.5 years (range 3.6-14.3), including 7 spayed females and 1 castrated male.
EVALUATION OF A MODIFIED TRANSFRONTAL CRAN-
A sagittal saw used to create a diamond-shaped opening in the frontal sinus. The rostral portion of the diamond was conventional in shape and design. Caudally, the bony opening was enlarged laterally compared to the conventional approach, via exposure enhanced by temporalis elevation. This afforded 68% (95% CI, 42-93%) wider access to the mid-frontal lobes when pre-operative imaging was assessed.
The procedure was easily combined with rostrotentorial craniectomy (n = 2). Median surgical time was 280 minutes (first 4 cases) or 170 minutes (subsequent 4 cases). Five dogs suffered complications but recovered fully: CSF rhinorrhea, cutaneous infection, subcutaneous emphysema, aspiration pneumonia, prolonged neurological recovery. There was 1 peri-operative death. Median hospitalization was 6 days. Magnetic resonance imaging confirmed complete resection (n = 5). Diagnoses were meningioma (n = 4), oligodendroglioma (n = 3) and granuloma (n = 1). Euthanasia occurred due to recurrence (n = 2; 9 and 12 months) and unrelated disease (n = 1; 8 months). Four patients remain alive (1-10 months). Median survival (Kaplan-Meier analysis) was 22 months.
A diamond-shaped opening of the frontal sinus, made wider caudally via elevating temporalis musculature, provides excellent access to the mid-caudal frontal lobes. Despite short-term complications, long-term outcome can be excellent. Inflammatory cytokines are potential modulators of infarct progression in acute ischaemic stroke. They are therefore possible targets for new treatment strategies in humans. From a translational research perspective, dogs with spontaneous ischaemic stroke offer an opportunity of studying the cytokine response in a non-invasive setup, and thus may complement current experimental stroke models.
IL-6 IS
The aim of our study was to investigate cytokine concentrations in plasma and cerebrospinal fluid (CSF) in dogs with acute ischaemic stroke, and to search for correlations between infarct volume and cytokine concentrations.
Blood and CSF were collected from dogs less than 72 h after a spontaneous ischaemic stroke. Infarct volumes were estimated on magnetic resonance images. IL-2, IL-6, IL-8, IL-10 and TNF in plasma, CSF and brain homogenates from the infarct core were measured employing a canine-specific multiplex immunoassay and compared to healthy control dogs.
IL-6 was significantly increased in plasma (P = 0.04) and CSF (P = 0.04) in stroke dogs compared to healthy controls. The concentrations of other cytokines, such as TNF and IL-2, were unchanged. Plasma IL-8 levels correlated significantly with infarct volume (Spearman r = 0.8, P = 0.013).
The findings of increased concentrations of IL-6 in CSF and plasma in dogs compare to previous findings in humans. This suggests that the inflammatory response in dogs with spontaneous stroke resembles that in humans, and that dogs could provide alternative opportunities for studies of the inflammatory processes that accompany stroke. No updates for canine peripheral nerve sheaths tumor (PNST) appeared in recent literature. The aim of this study was to evaluate the correlation between clinical aspects and MRI findings of tumors involving a major peripheral nerve, plexus or root and to determine the survival time in dogs treated with palliation, surgery or stereotactic radiotherapy (SRT).
POSTER PRESENTATIONS
Records of dogs with PNST evaluated from 2000 to 2014 were reviewed to determine signalment, duration of clinical signs, neurological examination, MRI features, treatment option (palliation, surgery, stereotactic hypo fractionated radiotherapy). Time to first event, survival times and statistical differences across categories were calculated by the Kaplan-Meier product limit method and log-rank test.
Forty-seven dogs (median age 9 years, male:female ratio 1.76) were included, with Labrador retrieveroverrepresented (17%). Roots lesions were the most frequent (46.8%), with C5-T1, V nerve and left side more involved (25.5%, 19.1% and 61.7%). Presenting sings were lameness, paresis and pain. Mean duration of clinical signs was 90 days. MRI findings comprises increased diameter, hyper intense and contrast enhancing nerve roots (57.1%), plexus or peripheral nerve (42.9%), focal hypomiotropy and muscle hyper intensity (73%). The time to first event was 30 days after surgery and 240 days after SRT. Overall mean survival was 97, 144 and 371 days with palliation, surgery and SRT. A predilection for Labrador retriever is observed.
Comparing our results with published data, SRT seem to promise better results than palliation or surgery and warrant further evaluation. The prognosis for canine nasal tumors with intracranial extension is poor with an expected survival of 1 month with palliation and 6.7 months with irradiation. However, studies regarding stage IV nasal tumors treated with brain-sparing irradiation techniques are lacking.
BRAIN-SPARING IRRADIATION OF STAGE IV CANINE
The aim of this prospective study was to evaluate feasibility and efficacy of definitive intent stereotactic radiotherapy in dogs with nasal tumors with massive intracranial extension.
Seven dogs with stage IV nasal tumors were treated with highdose hypo-fractionated stereotactic radiotherapy with VMAT technique. Dose prescriptions were 32-36 Gy in four consecutive-day fractions to the gross tumor and 30 Gy to limphatics. Adjuvant treatment included carboplatin. Serial clinical and CT/ MRI examination were performed. Disease control and toxicity effects were evaluated according to RECIST and VRTOG criteria. Median survival time (MST) was evaluated using Kaplan-Meier curves. Six carcinoma and 1 sarcoma were treated. Prescription goals were obtained in four cases with V95%>95% and V107%>2% whereas in 3 dogs V95% = 86-90% was accepted to limit maximum brain punctual dose <27 Gy. Two partial response and 5 complete responses were obtained. MST was 9 months. One grade II late brain radiotoxicity and two brain ascending infections were observed. Relapse pathways involves diffuse meningeal and sphenoid invasion.
The initial experiences with the RT regimen adopted indicate a feasibility and effectiveness in modified stage IV nasal tumors. The relapse pathways observed suggest to evaluate alternative adjuvant treatment in dogs treated with stereotactic radiotherapy. Limited information is available to inform differential diagnoses for meningiomas on canine magnetic resonance imaging (MRI). A retrospective study and a literature review of lesions with similar imaging appearance to meningioma was performed. Inclusion criteria were contrast-enhancing intra-dural extra-parenchymal MRI mass lesions and histologic confirmation. Brain and spinal lesions were eligible. Meningiomas and ventricular lesions were excluded. We investigated radiologic criteria that could aid in differentiating other etiologies from meningiomas.
CONTRAST-ENHANCING
Nineteen cases were retrospectively identified. Brain histological diagnoses included: histiocytic sarcoma (n = 2), granuloma (n = 2), glioma (n = 2), and craniopharyngioma (n = 2). There were single cases of granular cell tumor, hemangioblastoma, hematoma, esthesioneuroblastoma, gliomatosis cerebri and germ cell tumor. Spinal lesions included two intradural-extramedullary nerve sheath tumors, two nephroblastomas and an undifferentiated sarcoma. Irregular or indistinct margins were useful in discriminating from meningioma. Craniopharyngiomas and germ cell tumors were seen in the sella turcica region only. Otherwise, these lesions could not be readily distinguished from meningioma.
Literature review identified 93 cases, highlighting the frequency with which the following lesions are described as contrastenhancing extra-axial masses or preliminarily diagnosed as meningiomas: pituitary adenoma, nerve sheath tumors (trigeminal and spinal), granular cell tumor, lymphoma, glioma, fungal granuloma and histiocytic sarcoma. Sarcoma, metastasis and various sporadic pathologies were rare.
Many neoplasms and granulomas can have similar or identical MRI appearance to meningioma. A poorly defined or irregular margin on MRI might decrease the suspicion of meningioma. Differential diagnoses for sella turcica masses should include craniopharyngioma and germ cell tumor. Gliomas are among the most vascularized human solid tumours and are related with their poor prognosis. While neovascularization occurs by vasculogenesis in embryonic stages, angiogenesis is mostly related with adult tissue development. However, there are five different mechanisms by which gliomas achieve neovascularisation: vascular co-option (CO), angiogenesis, vasculogenesis, vascular mimicry (VM) and glioblastoma endothelial cell transdifferentiation. The objective of this study is to evaluate the neovascularization features of spontaneous canine gliomas.
Eighteen spontaneous canine gliomas were retrospectively selected from the databases of the Mouse and Comparative Pathology Unit of the Universitat Aut onoma de Barcelona, including 12 anaplastic oligodendrogliomas, 3 oligodendrogliomas and 3 glioblastomas. Vascular features were evaluated by slides stained with Hematoxylin-Eosin. The immunohistochemical study was performed by a semiquantitative evaluation of representative fields using CD31 as a mature endothelial cell adhesion protein marker and VEGFR-2 as an angioblast plasmatic membrane receptor cell marker.
The morphological study showed that low-grade gliomas (LGG) mostly display a generalized capillary proliferation and high-grade gliomas (HGG) mostly contains capillary glomeruloid formations (GC) in peripheral areas. Medical records were retrospectively reviewed for historical and neurological findings, histopathological diagnosis, and outcome. Ten dogs had TSH performed as therapy for their non-functional sellar masses. The Bulldog was the most common breed represented (4 dogs) and all but one breed represented were brachycephalic. Median body weight was 22.5 kg and median age at time of diagnosis was 8.8 years. Six dogs had a history of progressive dullness, 3 dogs had behavior or personality changes, 2 dogs had head or generalized tremors, and 2 dogs had vision loss. Neurologic findings included: dull mentation (7 dogs) with the other 3 dogs reported to be obtunded, delayed or absent conscience proprioception (5 dogs), and ataxia (3 dogs). Histopathology revealed that 4 dogs had chromophobe pituitary adenomas, 2 dogs had meningiomas, and one each of the following tumor types was seen: pars intermedia adenoma, ependymona, craniopharyngioma, and chromophobe pituitary adenocarcinoma. Overall median survival post-TSH was 232 days (range 0-1190 days). Median survival for dogs with adenomas was 487 days (range 182-1190 days).
Non-functional sellar masses were commonly identified in brachycephalic breeds and dull or obtunded mentation was commonly identified on neurologic examination. TSH may be an effective therapy for dogs with non-functional pituitary adenomas. Peripheral nerve sheath tumors (PNST) affecting the trigeminal nerve are relatively uncommon in dogs and few literature data regarding the best treatment are available.
VOLUMETRIC MODULATED ARC RADIOTHERAPY FOR
The aim of this work was to evaluate the feasibility and effectiveness of curative high dose hypo fractionated frameless Volumetric Modulated Arc Radiotherapy (VMAT). The primary endpoints were the recurrence or the progression of the tumor, the death from any cause and the death from the considered disease.
A prospectic clinical trial was conducted from February 2010 to December 2013 on client-owned dogs with presumptive imagingbased diagnosis of trigeminal PNST. The treatment was performed using a 6 MV linear accelerator equipped with an external beam micro-multileaf collimator. The plans were computed with Montecarlo algorithm. Overall survival was estimated using the KaplanMeier product method.
Seven dogs were enrolled and treated with 37 Gy in 5 fx. MRI follow-up examinations revealed complete response in 1 dog, partial response in 4 dogs, stable disease in 2 dogs as the best treatment results. No major complications occurred. One dog develop disease progression at 483 days and deceased for proven relapse at 523 days. Considering all deaths, mean and median overall survival were, respectively, 609 days (range, 313-952) and 952 days.
Comparing the obtained survival with previously published studies, VMAT appears to be safe, effective and offer the best median survival time in dogs suffering from trigeminal PNST. Due to the rarity of intracranial canine PNST, further multi center cooperative trials are advisable. Compressive hydrated nucleus pulposus extrusion (HNPE) is defined as an acute extradural compressive lesion consisting of hydrated nucleus pulposus material, occurring at the level of the associated intervertebral disc in dogs. Magnetic resonance imaging (MRI) is the imaging modality of choice to diagnose HNPE. This study examines the possibility to detect compressive HNPE with computed tomography (CT). A first objective of the study was to determine the capability of CT to detect HNPE and to describe the CT characteristics. The second objective of the study was to determine the sensitivity and specificity of CT to detect HNPE.
MULTISLICE COMPUTED TOMOGRAPHY FOR
A retrospective analysis of the clinical and imaging data of dogs diagnosed with compressive HNPE on MRI was performed. Both CT and MR images had to be available to be included. The CT images of MRI confirmed cases were assessed by a non-blinded image reader to define the CT characteristics. The sensitivity and specificity of CT to detect a cervical HNPE was determined by 2 blinded observers using a control group of dogs with acute type 1 disc disease.
HNPE was characterized on CT as a hypodense extradural compressive lesion dorsal to the intervertebral disc space with rim enhancement on postcontrast images. The sensitivity and specificity to detect HNPE with CT was respectively very good (91%) and excellent (100%). CT is a useful technique to detect compressive HNPE in dogs. However, if no clear lesion is identified with CT or if information about intramedullary changes is needed, MRI still needs to be performed. A clinical trial in spinal cord injured dogs demonstrated that implantation of autologous canine olfactory mucosa cells (cOMCs) lead to recovery of some motor function. However, not all dogs responded to cOMCs and there was no improvement in long-tract functionality. One strategy to enhance transplant-mediated regeneration is genetically engineering cOMCs to release therapeutic biomolecules. To achieve this clinically, magnetic particle (MP) based vectors are emerging as key non-viral alternatives for genetically engineering therapeutic cell populations. In particular, magnetofection with various magnetic fields has been shown to safely and efficiently transfect a range of neural cells.
ENGINEERING CANINE OLFACTORY CELL GRAFTS
Here, we optimised MP mediated gene delivery to cOMCs and demonstrated delivery of Brain Derived Neurotrophic Factor (BDNF; shown to promote repair in spinal injury) encoded by the advanced minicircle vector platform. Along with MPs, minicircles have significant advantages for translation compared to conventional plasmids, resulting from bacterial backbone removal. Therefore, they can incorporate larger genes, do not undergo transcription silencing and do not elicit immune responses, leading to higher safety.
Under the no-field condition, 86 AE 0.8% of cells displayed MP uptake and 34.9 AE 2.9% expressed the reporter gene. These values were significantly enhanced by application of all tested magnetic fields to ca. 95% (MP uptake) and 55% (transfection efficiency) whilst maintaining high cOMC viability. Minicircle encoded BDNF was successfully delivered to cOMCs (transfection efficiency of 8.1 AE 0.3%) resulting in a fourfold concentration increase of BDNF in conditioned media (transfected cells versus controls). This is a major refinement of the cOMC therapy now requiring testing in the clinic. Supra-sacral spinal cord injury, common following intervertebral disc herniation in dogs, causes dysfunction of urine storage and voiding leading to urinary incontinence and retention. Severe dysfunction of this nature is currently incurable and may lead to serious, even fatal, secondary complications.
URODYNAMIC CHARACTERISTICS OF NEUROGENIC
Our objectives in this study were to characterise lower urinary tract dysfunction in chronic supra-sacral spinal cord injury in dogs and analyse the relationship of bodyweight, chronicity and severity of injury with bladder compliance, to serve as baseline data for future clinical trials using this natural animal model.
After receiving ethical permission, we prospectively recruited dogs as part of randomized clinical trials on treatment for severe chronic (>6 weeks) thoracolumbar spinal cord injury for cystometric evaluation. Relationships of bodyweight, chronicity and severity of injury with compliance were analysed using logistic regression. In 84 dogs, mean bladder capacity was 73% of that expected for bodyweight. 58 dogs (69%) had premature urine leakage. Of 38 dogs in which it was measured, 21 (55%) had unprovoked involuntary detrusor contractions (median = 3 contractions/ cystometry -range = 1-11) during bladder filling with bladder pressure reaching a mean of 32.2 cmH 2 O (range = 10-54 cmH 2 O). 58/84 dogs had reduced bladder compliance (defined as <12.5 mL/ cmH 2 O) with a median of 5.8 mL/cmH 2 O (range = 2.8-16.5 mL/ cmH 2 O). Compliance was not associated with bodyweight, chronicity or severity of injury.
This population of spinal cord-injured dogs exhibited many features of lower urinary tract dysfunction also found in injured humans. It constitutes an available model to test putative therapies for abrogating the loss of bladder control caused by severe spinal cord injury. Estimation of the severity of thoracolumbar spinal cord injury (SCI) following canine intervertebral disc herniation relies on neurological examination. Cases lacking conscious pain perception (CPP) are problematic because: (i) many will recover but predicting an individual's prognosis is not possible; and (ii) assessing CPP is not standardised or truly objective. Having a means of objectively teasing out different severities of SCI within the 'deep pain negative' group would be useful.
ELECTROPHYSIOLOGICAL EVIDENCE OF SPINAL CORD
Our objective in this study was to describe the presence/absence of ascending somatosensory evoked potentials (SSEPs) and descending transcranial magnetic motor evoked potentials (TMMEPs) in the chronic phase of SCI in dogs.
After receiving ethical permission, we prospectively recruited 82 dogs as part of randomized clinical trials on treatment for severe (lacking CPP) chronic (>6 weeks) thoracolumbar SCI for electrophysiological evaluation under sedation. In 31 dogs in which brain recording was done, SSEPs could be detected over the left cortex in 9 (29%) (latency = 25.5 AE 2.9 ms, amplitude = 0.318 AE 0.196 lV) and over the right cortex in 5 (16%) (latency = 27.9 AE 3.0 ms, amplitude = 0.523 AE 0.323 lV) with 5 dogs having detectable waves bilaterally. In 51 dogs, we attempted to record sensory evoked spinal potentials but no wave could be recorded above the lesion. Of 82 dogs, TMMEPs could be detected in the left pelvic limb in 16 (19%) (latency = 57.4 AE 23.0 ms), in the right pelvic limb in 13 (16%) (latency = 54.0 AE 16.7 ms), and bilaterally in 9 dogs.
Dogs lacking CPP can be divided into 2 groups based on the presence/absence of SSEPs/TMMEPs. This distinction might help case selection to test putative therapies for SCI repair. An 8-week-old intact female Chihuahua was evaluated for acute tetraparesis progressing to non-ambulatory paraparesis. On neurologic examination, the patient was non-ambulatory tetraparetic with subtle motor and ataxia in the thoracic limbs and mild motor in the pelvic limbs. There was increased extensor tone with normal reflexes in all four limbs. Placing responses were absent in all four limbs and hopping was decreased to absent in all four limbs. The dog demonstrated discomfort over the calvarium and cervical spine. The neuroanatomic localization was to the cervical spine, with or without the involvement of the brain, based on the hyperesthesia.
ULTRASONOGRAPHIC IMAGING OF ATLANTOAXIAL
Ultrasound assessment of the cranium ruled out hydrocephalus and was used further to assess the craniocervical junction. A small curvilinear ultrasound probe was applied to the cranial neck and the C1 and C2 vertebrae were visualized in extension and with mild flexion. There was repeatable distraction of these bony landmarks and visualization of the spinal cord revealed kinking at the level of the atlanto-axial articulation. Radiographs and CT were performed to corroborate the suspected ultrasound diagnosis of atlantoaxial subluxation.
The relative safety of this procedure makes it more favorable than traditional radiography that usually requires flexion of the neck and can require general anesthesia. This imaging modality may be limited in its success to very young animals which are skeletally immature. Ultrasound can also potentially provide a more cost-effective preliminary diagnostic tool prior to pursuing more expensive diagnostics such as CT and MRI. Imepitoin has recently been registered for the management of dogs with idiopathic epilepsy (IE). Currently, there is no evidencebased information available on which antiepileptic drug (AED) to add to the treatment of dogs with IE that are not well controlled with imepitoin.
PHENOBARBITAL OR POTASSIUM BROMIDE AS AN
The goal of this study was to evaluate the efficacy of phenobarbital (PB) or potassium bromide (KBr) as an add-on AED for controlling dogs refractory to a maximum dose of imepitoin. The study was performed as a prospective, randomized, controlled clinical trial. The efficacy of PB or KBr was evaluated by comparing monthly seizure frequency (MSF), monthly seizure day frequency (MSDF) and the presence of cluster seizures during a retrospective 2-month period with a prospective follow-up period of 6 months. Also the 50% responder rate (RR) was investigated. Twenty-seven dogs were included in the study, 14 dogs in the PB group and 13 dogs in the KBr group. A significant decrease in median MSF and MSDF was found in the PB group (P = 0.001 and P = 0.001, respectively) and in the KBr group (P = 0.004 and P = 0.003, respectively). Overall, the number of dogs with cluster seizures decreased significantly (P = 0.0005). The RR was 79% vs. 69% in the PB and KBr group, respectively. We conclude that PB or KBr add-on treatment efficiently decreases median MSF and MSDF in dogs refractory to a maximum dose of imepitoin. Combination therapy was generally well tolerated and resulted in an improvement in seizure management in the majority of the dogs. Canine epilepsy MR imaging is still a diagnostic challenge for veterinary professionals. MR volumetry is technique of non-invasive volume measurement of the selected anatomical structures, that could allow to determine a possible structural changes in a CNS. Quantitative MR imaging in humans exceeds the findings of visual inspection of clinical MR imaging studies.
THE MR VOLUMETRIC BRAIN ASSESSMENT IN CANINE EPILEPTIC PATIENTS -
The aim of the work is to study the canine brains in terms of its volumetric construction designed to demonstrate the possible brain volume changes in canine epileptic patients as a possible model for human patients.
The study was carried out on 22 MRI scans (1.5T Ingenia Philips), 13 dogs with diagnosed idiopathic epilepsy (according to IVETF guidelines), 9 normal control. All dogs were patients of the Department of Internal Medicine and Clinic for Horses, Dogs and Cats, Faculty of Veterinary Medicine, Wrocław University of Environmental and Life Sciences, Poland. Analyzed MRI research dimensional sequence were T1-weighted (sT1W_3D, TE 5.2, TR: 25.0, FOV: 220, layer thickness: 0.8 mm, GAP: À0.4 mm, voxel size: 0.75 9 0.75 9 0.375). The analysis was conducted by using Slicer software (version 4.5.0). A ratio of ventricular system to brain tissue (V-B) was counted with special reference for white to gray matter (W-G) comparison. There was a significant difference in a V-B ratio in between the IE and control groups (respectively 0.0056-0.0153) found, and no difference in the W-G ratio (0.261-0.232).
These preliminary results suggest a possible reduce of the brain volume in epileptic patients with a preservation of the white-to gray matter ratio.
EPILEPSY AND COMPULSIVE DISORDERS IN DOGS.
C. Escriou, M. Garrone. Unit e de neurologie, VetAgro-Sup, Universit e de Lyon, Campus v et erinaire de Lyon, Marcy L'Etoile, France
There is a long-recognized association between obsessive-compulsive disorder (OCD) and chronic epilepsy in humans, most notably refractory temporal lobe epilepsy (TLE). In dogs, neurobehavioral comorbidities associated with development of epilepsy have been recently demonstrated. Compulsive disorder (CD) are well described in dogs with breed specific CD like breed specific idiopathic epilepsy. Our aim was to assess the association between CD and idiopathic epilepsy in a comparative design.
Fifty dogs diagnosed with idiopathic epilepsy in the neurology unit of a universitary referral center between the 01/01/2010 and the 31/12/2014 were enrolled. All dogs completed tier 1 and tier 2 diagnostic approach proposed by the "international veterinary epilepsy task force". 100 healthy non-epileptic dogs (2 healthy dogs (same breed, same age) for one epileptic dog) chosen in the referral center clinical database were enrolled as control. Owners were asked to complete a questionnaire designed to assess the presence or absence of all CD described in dogs during a telephone conversation conducted by always the same investigator.
Significant association were found between the CD pacing, head bobbing, self-biting, face-rubbing, self-licking, inanimate objects aggression, whining, chewing or eating objects, and polyphagiapolydipsia. Head bobbing and inanimate objects aggression was neither reported in control dogs.
Although antiepileptic drugs can induce some CD like polyphagia-polydipsia, our study is the first to assess comorbidities between CD and idiopathic epilepsy in dogs. As some CD remains infrequent behavior, our results probably underestimate their link with idiopathic epilepsy and increasing statistical strength of the study with larger population is mandatory. Canine degenerative myelopathy (DM) is a late onset disorder characterised by progressive general proprioceptive ataxia and paresis of the pelvic limbs which progresses to affect the thoracic limbs. A missense mutation (118G>A) in the superoxide dismutase 1 gene (Sod 1) is associated with DM but it is unclear how this mutation leads to the disease.
AN ASSESSMENT OF NEURONAL CELL BODY AND SYNAPTIC TERMINAL DENSITY IN THE SPINAL CORD AND RED NUCLEUS OF CANINE DEGENERATIVE
The purpose of this study was to determine if pathology in specific anatomical regions could account for clinical features of the disease. Specifically, we investigated whether the accumulation of SOD-1 in neurons impacted on the density of neuronal cell body and synaptic terminals in the thoracic and cervical regions of the spinal cord and the red nucleus.
Immunohistochemistry was performed on paraffin embedded sections from both control and DM cases and staining intensity was quantified using Image J software. SOD1 staining was higher in spinal cord regions of DM dogs compared with controls but the density of neuron cell bodies was comparable. The synaptic density was unchanged in both the thoracic or cervical spinal cord. However, in the red nucleus, SOD1 staining was comparable between control and DM but synaptic density was significantly decreased in DM.
In conclusion, the results of this study suggest the accumulation of SOD1 does not alter neuronal density, however it has an impact on synaptic density in the red nucleus, one of the brainstem nuclei involved with motor co-ordination and may relate to clinical features associated with DM. Ethical approval was granted for use of all tissues in this study.
VISUALIZATION OF INTRACRANIAL VESSELS IN TOY-BREED DOGS USING THREE DIMENSIONAL TIME-OF-FLIGHT MAGNETIC RESONANCE ANGIOGRAPHY.
C. Ishikawa, D. Ito, N. Tanaka, S. Ohta, M. Kitagawa. School of Veterinary Medicine, Nihon University, Kanagawa, Japan Accurate visualization of canine intracranial vessels using three dimensional time-of-flight magnetic resonance angiography (3D TOF MRA) have been reported, which were evaluated dogs with more than 9 kg. We hypothesize that image quality of intracranial vessels between small-sized (toy-breed) dogs and large-sized dog might be different, as vessels in small-sized dog would be thinner than those in large-sized dog. Therefore, the aim of this study was to evaluate image quality of intracranial vessels in small-sized dogs using 3D TOF MRA. This study was approved by Nihon University Animal Medical Center ethical committee. Five small-sized dogs (mean body weight 2.8 kg) were enrolled, which were diagnosed as idiopathic epilepsy using 1.5T MRI. A total of 13 intracranial arteries were evaluated on MIP images. For each vessel, image quality was reviewed by three veterinarians, and divided into four categories: excellent, good, fair and poor. Excellent and good were assessed as worth of diagnostic image.
Segment of the internal carotid artery in three of five (3/5) dogs and the rostral cerebellar artery in 2/5 dogs were evaluated as fair or poor. Most of remaining vessels was evaluated as excellent or good.
In conclusion, segment of intracranial carotid artery and rostral cerebellar artery in small-sized dogs might not be clearly identified using 1.5T 3D TOF MRA. As they were identified in previous studies using 3T, visualization of them might be affected by not only body size but field strength of MRI. Intracranial vessels in toy-breed dogs could be evaluated using this method, although further studies are necessary to evaluate about image quality of vessel on 3D TOF MRA. Diagnosis of hydrocephalus is to obtain image observation of the ventriculomegaly. In human, time spatial labeling inversion pulse (time-SLIP) is used to research about cerebrospinal fluid (CSF) dynamics. In dogs, it is thought that common causes of congenital hydrocephalus are flow obstacles of CSF, but actual CSF dynamics in dogs was not understand. Therefore, we investigate CSF dynamics in dogs with hydrocephalus using time-SLIP. This study was approved by Nihon University Animal Medical Center ethical committee. Two dogs that diagnosed stenosis/obstruction at outlet of the forth ventricle on conventional MRI and one dog with aqueduct stenosis/obstruction was underwent further images, time-SLIP. We observed CSF dynamics at the aqueduct and pre-pontine cisterns on mid-sagittal brain.
CEREBROSPINAL FLUID MOVEMENT USING MAGNETIC
In all dogs, CSF flow (one direction movement) was observed in the aqueduct and the pre-pontine cisterns.
It is conceivable that CSF flow in the aqueduct and CSF circulation of outside of the ventricular system would stop when CSF flow in the aqueduct is obstructed completely. However CSF flow was observed in the aqueduct and the pre-pontine cisterns. Therefore the cause of hydrocephalus might be stenosis of the aqueduct, not obstruction.
CSF flow at the pre-pontine cisterns might be affected in dogs with stenosis/obstruction at outlet of the forth ventricle. Because dilation of the fourth ventricle compress the brain stem and space of the cistern would be getting thinner. But again, CSF flow was observed at both pre-pontine cistern and aqueduct, this mean the isle of CSF at exit of the fourth ventricle was not closed. Studies in animal models, in which internal hydrocephalus has been induced by obstructing the cerebrospinal fluid pathways, have documented an up-regulation of the concentrations of aquaporin-4 (AQP4) in the brain. In this study, the concentrations of aquaporin-1 (AQP1), AQP1, AQP4 and Interleukin-6 (IL-6) were determined in the CSF of dogs with idiopathic communicating hydrocephalus before and after the reduction of intraventricular volume following ventriculo-peritoneal shunt (VP-shunt) treatment.
The concentrations of AQP4 and IL-6 were increased in the cerebrospinal fluid of dogs with hydrocephalus compared to controls. Both parameters significantly decreased after surgical treatment, accompanied by decrease of ventricular size and the clinical recovery of the dogs. AQP1 was not detectable in CSF.
Brain AQP4 up-regulation might be a compensatory response in dogs with hydrocephalus. Future determination of AQP4 at the mRNA and protein level in brain tissue is warranted to substantiate this hypothesis.
SOUND LOCALISATION IN DOGS WITH VESTIBULAR DISEASE:
A PRELIMINARY STUDY. P. Gardiner, P. Freeman. Department of Veterinary Medicine, University of Cambridge, UK Vestibular disease is a common neurological presentation in small animal practice and has many possible aetiologies. An important step in the investigation of vestibular disease is to determine whether the signs are caused by a peripheral or central lesion, as this informs both the prognosis and the most appropriate diagnostic investigations. In human medicine determining whether there is any hearing loss associated with the vestibular signs is part of the initial assessment. This information aids in localisation of the lesion as unilateral deafness is common in peripheral vestibular disease but rare in central disease. Demonstrating unilateral deafness in dogs relies on specialist equipment to investigate brainstem auditory evoked potentials (BAEP), and the equipment required for this is not widely available in first opinion practice.
This study used a simple test involving a squeaky toy suitable for use in first opinion practice to demonstrate localisation of sound in dogs.
The preliminary component of the study establishes a baseline of responsiveness in 39 healthy dogs with which to compare animals with vestibular disease. It also establishes and validates the test protocol as a practical way of measuring this response to sound.
NOISE INDUCTED HEARING LOSS IN A POLICE DOG.
D. W. Hague. Veterinary Clinical Medicine Dept., University of Illinois, Urbana, Illinois A 4 year old intact male Belgium Malinois was evaluated for acute hearing loss. The dog was a working police dog involved in a training exercise where a gun was fired five times on his right side. The estimated noise level was approximately 140 decibels. Later that day, the dog was involved in bite work and the handler noted the dog was not responding to verbal commands. He presented three days later for evaluation of hearing. There was no evidence of any abnormalities on neurologic or physical examination.
Brainstem auditory evoked response (BAER) testing was performed in both ears with a 70 and 90 decibel click stimulus using a mastoid reference and masking tone in the opposite ear. There was evidence of an absence of waveforms. Based on the history, the patient was diagnosed with a noise-induced hearing loss. Two weeks later, a repeat BAER test showed evidence of intact waveforms (I-V) in both ears. The handler reported the dog was responsive to oral commands. This case represents the risk of noise-induced hearing loss in working dogs. Therefore, hearing protective devices should be considered in working dogs exposed to episodic or chronic loud noises. Muscle fibre death in immune-mediated inflammatory myopathies is poorly understood. MHC-II myocytic expression in CIMM represents a shift towards an antigen presenting cell phenotype and breaking of immuno-tolerance. Autophagy can impact the immune response through its role on antigen delivery to the MHC. In order to unravel myofibre death mechanisms we investigated autophagy and apoptosis in CIMM.
AUTOPHAGY VERSUS APOPTOSIS -MYOFIBRE DEATH IN CANINE IMMUNE MEDIATED MYOSITIS (CIMM
Thirty four CIMM dogs (11 MMM and 23 PM), 10 dogs with non-inflammatory myopathy, 10 dogs with neurogenic muscle atrophy and 4 dogs without neuromuscular disorders were evaluated immunohistologically for the expression of MHC-II, LC3 and Cleaved Caspase-3 in muscle biopsies. Their expression was semiquantitatively scored and sorted for subcellular distribution (MHC-II) after which group specific data were obtained according to standard algorithms.
CIMM presented with significantly higher (P < 0.05) scores for MHC-II and LC3 if compared to the other diseases and controls, while Cleaved Caspase-3 was not expressed by myocytes throughout the groups. There was no difference in MHC-II and LC3 expression in MMM and PM. No correlation could be found between MHC-II and LC3 in CIMM.
MHC-II regulation seems to be driven by inflammation rather than be triggered by autophagy with subsequent exposure of selfantigens to T helper cells. However increased expression of LC3 with activation of macroautophagy might be responsible for sarcopenia in course of CIMM together with direct destruction of myofibres by inflammatory infiltrates. Lack of Cleaved Caspase-3 expression on the other hand suggests that myocytes do not undergo apoptosis and T-cells exert their lethal hit by a different mechanism. The aim of this study was to describe the cerebrospinal fluid (CSF) metabolites identified and quantified by 1 H NMR spectroscopy in four dogs with polyradiculoneuritis (PRN). The diagnosis was fixed based on clinical appearance (acute flaccid tetraparesis, dysphonia) and electrodiagnostic tests (positive sharp waves and complex repetitive discharges on EMG, and slow NCS). The CSF samples were harvested from altantoccipital space under general anaesthesia and they were analyzed for proteins and cells. The 1 H NMR spectra were recorded from four dogs with PRN and were compared with those obtained from 10 healthy dogs, 13 metabolites being identified and quantified. The data were analyzed with PASW Statistics 18.
H NMR CEREBROSPINAL FLUID PROFILE IN DOGS
On routine examination, the CSF samples were characterized by a normal number of cells (<5 cells/lL) with normal or a moderate increase of protein amount (<40 mg/L). Using Our results may suggest that in PRN CSF reflects a major alteration in the energetic metabolism of the neurons, similar with those reported in humans' central nervous system chronic demyelinating diseases. Carmichael Torrance Veterinary Diagnostic Laboratory A 5-year-old domestic cat presented with acute onset of ataxia, depressed mentation, hyperaesthesia, hypothermia, and continuous twitching/seizure activity in the morning after having been outside overnight. Despite immediate treatment, the cat progressed within 24 h to a comatose state, opisthotonus and severe miosis unresponsive to light. Given a poor prognosis, euthanasia was elected. Gross findings were disappointing and consisted of a non-specific lung oedema and congested lungs and spleen. Surprisingly, within the stomach and intestines, fragments of cockshafers were found. Histologic examination confirmed the gross findings and additionally showed evidence of mild brain oedema, but failed to identify a cause for the severe clinical symptoms. In a final attempt to solve the case, a urine sample was tested for toxic substances and it was found to contain a significant amount of alpha-chloralose.
ALPHA-CHLORALOSE POISONING IN
Alpha-chloralose (AC), a chlorinated acetal derivative of glucose, is used as a rodenticide, avicide and repellent, often in form of hypnotic baits to immobilize and live-capture pest animals. It is moderately toxic to mammals and fish, and highly toxic to birds. In animals, accidental AC poisoning is only poorly reported. The most common clinical signs are seizures, muscle tremor, hyperaesthesia, hypothermia, salivation, miosis, stupor, coma and ataxia. Coma and hypothermia was more common in cats, whereas salivation, ataxia and hyperthermia was more frequently seen in dogs.
AC poisoning in pet animals within Europe or the United States is poorly reported and no case has been described within the UK, as far as the authors are aware. Two full-sibling Hungarian Vizsla puppies from a litter of nine presented with progressive ataxia, starting around three months old. Clinical signs included cerebellar ataxia, truncal sway, intention tremors, absent menace responses and nystagmus in one dog. Routine diagnostic investigations were unremarkable, and magnetic resonance imaging in one dog demonstrated cerebellar atrophy. Euthanasia was elected shortly after the onset of signs. Histopathological examination revealed primary Purkinje neuron loss consistent with CCD. Whole genome sequencing identified a disease-associated splice donor site variant in the sorting nexin 14 gene (SNX14) as a strong causative candidate. An altered SNX14 splicing pattern was demonstrated by RNA analysis, and no SNX14 protein could be detected in CCD case cerebellum by western blotting. Genetic screening of 133 unaffected Hungarian Vizslas revealed three heterozygotes, supporting the presence of carriers in the wider population.
GENOME SEQUENCING REVEALS A SPLICE DONOR SITE MUTATION IN THE SNX14 GENE ASSOCIATED WITH
SNX14 is involved in maintaining normal neuronal excitability and synaptic transmission, and a mutation causes autosomal recessive cerebellar ataxia and intellectual disability syndrome in humans. This is the first report of CCD in Hungarian Vizsla dogs and identifies a splice donor site mutation in SNX14 as the likely cause, with an autosomal recessive mode of inheritance suspected. Minnie Animal Hospital, Chiba, Japan, 4 Laboratory of Veterinary Clinical Pathology, the University of Tokyo, Tokyo, Japan, 5 Laboratory of Veterinary Pathology, the University of Tokyo, Tokyo, Japan Aspartoacylase (ASPA) deficiency, also called Canavan disease in humans, is a rare autosomal recessive neurodegenerative disease and is a type of leukodystrophy. The deficiency is caused by mutations in the ASPA gene. Absence of ASPA activity results in accumulation of N-acetylaspartate (NAA) in the brain, visceral organs, and urine. In animals, naturally occurring ASPA deficiency has not been reported yet. Recently, ASPA deficiency was diagnosed in a domestic cat with leukodystrophy, and a candidate causative mutation was identified in the feline ASPA gene.
ASPARTOACYLASE DEFICIENCY IN
A 4-month-old female domestic cat weighting 1 kg was presented with frequent vomiting, head tremors, and frequent falling due to body imbalance. Magnetic resonance imaging showed T2-weighted hyperintensity and T1-weighted hypointensity in the brain stem and cerebellum. Gas chromatography-mass spectrometry analysis of the urine revealed unusual excretion of NAA, which is indicative of ASPA deficiency. The cat finally died at 7 months of age, and histopathological spongy degeneration was observed in the cerebrum and cerebellar region. Direct sequence analysis identified a homozygous missense mutation in the coding region of the feline ASPA gene. A genotyping survey using real-time PCR did not detect this mutation in approximately 1,000 domestic cats, thereby suggesting that this mutation is most possibly a causative mutation in this disease. Ethical approval for this study was obtained from the Animal Research Committee at Kagoshima University (approval number VM15041).
In conclusion, this is the first report of naturally occurring ASPA deficiency in animals, and the cat represents a model of human Canavan disease. A 6-year-old, neutered male Scottish Terrier was referred for progressive lethargy and anorexia of a week duration. Neurological examination revealed a low head carriage, hind limb ataxia, and decreased bilateral nasal sensation localising the lesion to the forebrain. MRI of the brain revealed a rounded, well-defined, central mass measuring 12 mm in diameter located dorsally and slightly rostrally to the pituitary fossa. The mass was slightly hyperintense to cortical grey matter on T2W, hypointense on T1W and without T2* signal void. There was a central fusiform enhancement of the mass after contrast administration suggestive of neoplasia. T4 and TSH levels raised the suspicion of secondary hypothyroidism. The cortisol ACTH ratio was < 0.0132 suggestive of primary hypoadrenocorticism. During hospitalisation, the dog developed an acute severe hypernatremia and died. Post mortem examination showed a severe lymphocytic panhypophysitis with extension to the hypothalamus; most lymphocytes were CD3 positive T-cells. Immunohistochemistry for Neospora caninum antigen was negative.
HYPOPHYSITIS IN A SCOTTISH TERRIER WITH ASSOCI-ATED PANHYPOPITUITARISM AND HYPOTHALAMITIS
To the authors' knowledge, a lymphocytic panhypophysitis with extension to the hypothalamus has never been reported. Hypothalamic involvement in autoimmune hypophysitis has rarely been described in people and usually manifests with central Diabetes Insipidus as suspected in our case due to the sudden onset of severe hypernatremia. This is the first MRI description of autoimmune hypophysitis in a dog. Like in humans, the clinical and MRI findings can be difficult to differentiate from other more common pituitary masses. Therefore, transphenoidal biopsies may be required for conclusive histopathological diagnosis and prompt institution of adequate treatment. A 3-year-old male neutered domestic short haired cat was presented with progressive lethargy and abnormal behaviour.
COMPUTER TOMOGRAPHY (CT) GUIDED DRAINAGE OF A BRAINSTEM ABSCESS IN
Clinical exam found cardiovascular signs suggestive of raised intracranial pressure. Neurological examination found obtunded mentation, non-ambulatory tetraparesis with left sided pleurothotonus and intermittent decerebellate rigidity. The postural responses were reduced in all four limbs, worse on the right. Cranial nerve evaluation found absent menace response and reduced facial sensation on the right, vertical positional nystagmus, anisocoria (right sided mydriasis) and an absent pupillary constriction on the right in response to direct and indirect PLR. Neurolocalisation was to multifocal lesions involving the right brainstem and forebrain.
Magnetic resonance imaging of the brain revealed a large, welldefined, predominantly fluid-filled extra-axial mass causing severe dorsal displacement of the pons and the medulla oblongata and cerebellar vermis herniation through the foramen magnum. These findings were most consistent with an intracranial abscess.
Emergency CT-guided needle drainage of the space-occupying lesion was performed through the soft palate and basioccipital bone. Bacteriology revealed heavy growth of Arcanobacterium haemolithicum and mixed growth of pleomorphic, mainly Gramnegative rods (Cl.hastiforme, Cl.Septicum, Cl.perfringens and Treponema/Serpulina spp). At discharge the cat had normal mentation and mild ambulatory tetraparesis. Broad-spectrum antibiotics based on culture and sensitivity were continued for 8 months and repeat imaging prior to withdrawal found complete resolution.
Follow-up examination 16 months later found only mild right sided postural reaction deficits that did not affect quality of life.
CT guided drainage of a brainstem abscess is not without risk however in this case it reduced intracranial pressure and provided a diagnostic sample. The proprioceptive positioning response (PPR) and patellar tendon reflex (PTR) are clinical tests commonly used to assess and localise neurological conditions in dogs. The primary aim of this study was to investigate the specificity of these tests by evaluating test outcomes in the hindlimbs of a population of dogs showing no overt signs of neurological disease. The secondary aim was to investigate the influence of age on these tests.
EVALUATION OF THE PROPRIOCEPTIVE POSITIONING
Twenty-nine dogs without evidence of neurological or hindlimb orthopaedic disease were selected and divided into two groups: A (<10 years-old, n = 20) and B (≥10 years-old, n = 9). A European Specialist in Veterinary Neurology, blinded to the age of the dogs, performed the tests.
The PTR was considered normal in all of the study population, while the PPR was abnormal in 17% of the dogs. The proportion of dogs with an abnormal PPR in one or more hindlimb was 10% in group A and 33% in group B; this difference was not statistically significant (P = 0.29). Only dogs in group B had bilateral PPR deficits (22%), but this difference between groups was not statistically significant (P = 0.089).
The finding that some dogs had PPR deficits despite having no overt neurological disease has implications for neurological examination interpretation: deficits should be interpreted with caution. There was no statistically significant difference in the proportion of PPR deficits between the two age groups. The PTR was normal in all cases, suggesting a lower prevalence of absent patellar reflexes in the general population than recorded in previously published literature. Canine Degenerative Myelopathy (DM) is associated with a substitution mutation of a glutamic acid (E) to lysine (K) residue in SOD1 (E40K) which increases its tendency to aggregate in cells. E40 is highly conserved across mammalian species with the exception of horses, which naturally express a K residue. We hypothesised that normal horse SOD-1 has the same tendency to aggregate as mutant DM-affected dog SOD1 in contrast to its E40 counterpart.
SPECIES-SPECIFIC DIFFERENCES IN CELLULAR AGGRE-GATION AND LOCALISATION OF VIRALLY-TRANS-DUCED MUTANT AND NORMAL CANINE AND EQUINE
cDNAs from wild-type (E40) and mutant (K40) canine SOD1 and wild-type (K40) equine SOD1 were amplified by PCR and cloned with N-terminal GFP-tags. PCR-mutagenesis was used to create an equivalent equine E40 SOD1 variant. Inserts were subcloned and transduced, alongside a GFP-only vector as lentiviral particles into human neuroblastoma cells (SHSY-5Y). Aggregates (nuclear or cytosolic) were quantified following fluorescence microscopy, in a blinded fashion (n = 3 coverslips per variant, on 3 separate occasions; minimum of 1500 cells counted per condition).
There were significantly more cytoplasmic SOD1 aggregates in the GFP-mutant dog SOD1 expressing cells (mean %AESEM; 23%AE5), compared to the wild-type dog (6.7%AE1.3) or GFP-only vector (1.7%AE0.5) (P < 0.05); there were significantly more nuclear aggregates in both GFP-horse SOD-1 variants (K40: 50.4%AE5.2, E40: 68.1%AE4.9) compared to the GFP-only vector (8.2%AE1.2) (P < 0.05).
These results suggest that there are species-differences in vitro in the tendency of mutant and normal SOD1 proteins to aggregate and localise. Cerebral amyloid angiopathy (CAA) is defined as the deposition of beta amyloid proteins within leptomeningeal and cortical vessels, being associated to Alzheimer disease and canine cognitive disease.
COGNITIVE DEFICITS AND PATHOLOGICAL FEATURES
This study aimed to evaluate in elderly dogs the association between cerebral amyloid deposition and pathologic lesions in the development and clinical manifestation of cerebral dysfunction. Local ethical permission was obtained for this study.
Gross evaluation of 44 brains of elderly dogs revealed cortical atrophy and ventricular widening in 22.7% (10/44) specimens. Congo red stain was utilized to classify the 61.4% (27/44) positive dogs (9-19 years old, mean 13.9 years old) to CAA. CAA were graded in mild (13/27 dogs), moderate (3/27 dogs) and severe (11/ 27 dogs). In all groups the most common clinical sign was disorientation. By the immunohistochemistry using polyclonal anti-beta amyloid 1-42 antibody, the average of positive vessels to betaamyloid increased with age. Association of cortical atrophy, neuron loss and micro hemorrhages contribute to the developing of cognitive deficits.
The consistent presence of this change in a variety of dogs above the age of 13 years, the correlation with intracerebral hemorrhage, and the similarity of the affected regions between dogs and humans, all uphold the utility of aged dogs as a natural model for studies about cerebral amyloid angiopathy. Cerebellar disorders in dogs can be subclassified into congenital, developmental and abiotrophic/degenerative types. Among the abiotrophies, the term cerebellar cortical degeneration (CCD) has been introduced lately, which includes an uncommon form mainly affecting granular cells. This variant has been described in several breeds including the Coton de Tulear. In this specific breed an immune-mediated disease process has been suggested. In this case report we describe a late stage presentation of a cerebellar granuloprival degeneration.
THREE YEARS AFTER CLINICAL ONSET OF CEREBEL-LAR CORTICAL DEGENERATION IN
A 7-month-old, Coton de Tul ear was presented with a history of progressive ataxia. The puppy was clear of the breed specific neonatal cerebellar ataxia.
Neurological examination revealed generalised ataxia, hypermetric gait, head tremors, decreased proprioception in the hind limbs and an inconstant bilateral menace response.
MRI revealed a cerebellum mildly decreased in size and a normal cerebrospinal fluid analysis. Clinical signs progressed over time and the dog was euthanized at the age of 3 years.
Histopathology confirmed diffuse, chronic and severe granuloprival cerebellar cortical degeneration accompanied by severe gliosis of the cerebellum. Signs of inflammatory infiltrates were not detected on conventional stains and immmunohistochemistry.
This Coton de Tulear appears as the first report of a chronic form of granuloprival CCD in this breed. Although the lack of inflammatory cells could suggest the absence of an immune mediated disease, these findings are most likely stage related and might reflect successful removal of the immunogenic target.
Further studies should focus on the research of a genetic mutation associated with these histologic findings. Glial fibrillary acidic protein (GFAP) is the main intermediate filament protein in astrocytes and a potential biomarker for intracranial disorders. The hypothesis should be proven that severe brain tissue destruction leads to measurable GFAP serum levels independent of the cause of the disease. Furthermore, it should be proven that GFAP levels in cerebrospinal fluid (CSF) are reflecting disease categories.
EVALUATION OF GFAP LEVELS IN SERUM AND CERE-
Six healthy Beagles and patients (n = 198) with the clinical diagnoses idiopathic epilepsy, brain tumor, inflammation, spinal cord injury (SCI) and traumatic brain injury (TBI) were included. GFAP concentrations were determined by ELISA. In serum, GFAP was only measurable in single cases. However, all CSF samples were positive for GFAP. Using Wilcoxon test, significant differences were found between GFAP CSF levels of dogs with tumor and epilepsy (P < 0.0004) and between inflammatory diseases and epilepsy (P < 0.0408). There was no correlation between GFAP values and severity, type and seizure frequency and severity of neuroparenchymal damage. In TBI patients high serum GFAP levels had a strong correlation with the Glasgow Coma Scale score. In dogs with SCI no significant difference between chronic and acute cases and severity of clinical signs could be detected.
In conclusion, GFAP cannot be recommended as a marker for a specific disease. However, serum levels in TBI patients may have predictive value for the outcome. Idiopathic eosinophilic meningoencephalitis (EME) is a rare condition of unknonw etiology and has been described in different breeds such as Golden Retriever, Rottweiler, Yorkshire Terrier, etc 1 . When the eosinophils in the cerebrospinal fluid (CSF) is <5%, this finding is considered nonspecifit; it is recommended that an eosinophilia of 10% of the total white cells in the CSF should be used as a minimum criteria for the diagnosis of EME in people 2 . This retrospective study described 8 cases of EME seen in a private referral practice in Hong Kong from 2009 to 2015, affecting several breeds of dogs. EME is a rare condition and makes up to 4.6% of all the MUE cases seen in a Hong Kong referral clinic from 2009 to 2015. The clinical presentation and MR images were variable and diagnosis was mainly made by the presence of eosinophilic pleocytosis of CSF. In general they carry good prognosis following immunosuppresive treatment, with 5 out of 8 cases (62.5%) in remission (off treatment) and 1 (12.5%) only needed AED due to persistent seizure. Increased levels of endocannabinoids were recently found in CSF of dogs suffering from Steroid-Responsive Meningitis-Arteritis (SRMA) and Intraspinal Spirocercosis (IS) (Abstract ECVN 2013). These endogenous ligands interact with two main types of cannabinoid receptors (CB1 and CB2). The CB2 receptor is highly expressed in inflammatory cells and is up-regulated in early phases of inflammation in cells of the CNS.
EIGHT CASES OF EOSINOPHILIC MENINGOENCEPHALI-TIS (EME) IN DOGS
CANNABINOID RECEPTOR TYPE 2 (CB2) EXPRESSION IN CANINE STEROID-RESPONSIVE MENINGITIS-ARTERITIS
In the present study, CB2 receptor expression was evaluated in spinal cord lesions of dogs with SRMA (n = 8) and IS (n = 2) and compared to healthy control dogs (n = 6). Therefore, a rabbit polyclonal anti-human CB2 antibody (LSBioÒ) was established on canine paraffin-embedded tissue samples using routine immunohistochemistry.
In cervical, thoracic, and lumbar spinal cord sections of dogs with SRMA and IS, CB2 was strongly expressed on the cellular surface of infiltrating leukocytes (i.e. neutrophils, eosinophils, lymphocytes, plasma cells, and macrophages). In SRMA, CB2-positive inflammatory cells were located within the adventitia of vessels, perivascular, subdural, subarachnoidal, and within white and grey matter. Moreover, moderate to strong CB2-positive endothelial cells and arachnoid mesothelial-like cells were present. In IS, CB2-expressing leukocytes were found adjacent to the parasite accompanied by severe necrosis and haemorrhage. Both diseases showed CB2-positive glial cells exhibiting a moderate to strong membranous signal. Likewise, scattered myelinophages and spheroids stained intensely positive with CB2. Dorsal and ventral neurons showed inhomogeneous slight to strong cytoplasmic immunoreactivity.
The present study demonstrates CB2 expression in inflammatory lesions of SRMA and IS and highlights the endocannabinoid system as a potential target for treatment of inflammatory CNS diseases. An 11-year-old mixed breed dog was presented with an acute onset of cluster seizures. At presentation, the dog showed a status epilepticus, which could be interrupted with anticonvulsive medication. Due to the stuporous state of the patient the following day, a thorough neurological examination could not be performed.
MRI of the head revealed an inhomogeneously contrast enhancing mass within the right frontal lobe adjacent to the cribriform plate and extending caudally to the rostral thalamus. CSF analysis showed a severe pleocytosis of 11540 cells/μL with 70% neutrophils and 30% monocytes and a protein of 2.63 g/L. Based on MRI findings and CSF analysis main differentials were intracranial abscess versus neoplasia. Surgery was performed and a major part of the intracranial mass was removed through a bilateral transfrontal approach. Histological examination revealed a WHO grade I conforming meningothelial meningioma with multiple intratumoural microabscesses. Neither the CSF nor the mass itself showed bacterial growth. The dog recovered well over the following 7 days and was discharged for radiotherapy at which time the dog was neurological unremarkable.
This case report illustrates that even a severe neutrophilic pleocytosis in the CSF cannot rule out an intracranial neoplasia. To our knowledge this is the first report of a meningioma with sterile microabscesses in a dog. Marked differences in clinical presentation and outcome between cervical and thoracolumbar disc extrusions have only been partially explained. We have recently shown that the inflammatory response in the epidural space has an impact on the outcome in thoracolumbar IVD extrusions.
CLINICAL AND EPIDURAL HISTOPATHOLOGICAL DIF-
The aims of the present study were to evaluate clinical data and histopathological parameters of epidural material from 55 dogs with cervical IVD extrusion, and to compare these data to those from 80 dogs with thoracolumbar IVD extrusion from a previous study.
Cervical epidural material was histologically examined, and associations between severity of inflammation and selected clinical and pathological parameters, impact of chondrodystrophic phenotype, and anatomic localization were evaluated statistically.
Dogs with a cervical IVD extrusion were significantly older (P < 0.001), had less severe and a longer duration of neurological signs (both P < 0.001), were more painful (P = 0.038), had a better outcome (P = 0.005), and revealed less severe calcification (P = 0.002) and inflammation (P < 0.001) in histopathology than dogs with a thoracolumbar IVD extrusion. No significant differences regarding chondrodystrophic phenotype were found.
In conclusion, the present study revealed obvious differences in clinical presentation and epidural space pathology between cervical and thoracolumbar IVD extrusions. Notably, there was a significantly less intensive epidural inflammatory response in the former. This correlated positively with a significantly lower degree of nucleus pulposus calcification in cervical extrusions indicating biochemical/ metabolic and biomechanical differences between the two locations which remain to be characterized in future studies. Somatosensory evoked potentials (SEPs) and transcranial motor evoked potentials (TMEPs) provide information regarding sensory and motor pathways, and dogs are considered translational models for naturally-occurring spinal cord injury. Our aim was to describe SEPs and TMEPs technique in uninjured and in affected chondrodystrophic dogs (CD). Paraplegic CD (5 with pain perception, 5 with loss of pain perception) due to thoracolumbar disc extrusions confirmed by computed tomography; and 5 neurologic normal CD were anesthetized with Fentanyl and Propofol in a continuous infusion rate.
SOMATOSENSORY AND MOTOR EVOKED POTENTIALS
SEPs were recorded with electrodes positioned subcutaneously on scalp following median and tibial nerves stimulation. TMEPs were obtained by electrical stimulation applied transcranially and captured via electrodes inserted into extensor carpi radialis and cranial tibial muscles.
SEPs waves were identified in all dogs after median nerve stimulation, and 5 dogs had no SEPs recordings on pelvic limbs, and they were clinically without pain perception. TMEPs were recorded on thoracic limbs in all dogs, but were severe attenuated in 7 dogs and absent in 3 dogs. Even if no voluntary movement could be detected clinically, electrophysiological responses were present caudal to spinal cord lesion, i.e., these patients may be paraplegic from clinical assessment, but not concerning electrophysiological function. All neurologically normal CDs presented SEPs and TMEPs on pelvic limbs.
Combined SEPs and TMEPs techniques appear to be reliable for spinal cord lesion evaluation under general anesthesia. TMEPs could be detected caudal to the lesion even in severely affected patients, possibly being a useful tool for spinal cord therapies evaluation. Thirty-three paraplegic dogs with acute or subacute thoracolumbar SCI were prospectively recruited and tested for presence or absence of DPP. MRI including T2W and diffusion tensor sequences of the thoracolumbar spinal cord was performed using a 3T MRI scanner. IMHL was measured and compared to the length of L2 vertebral body; FA values were obtained from SCI epicentre and one vertebral body cranially and caudally of the lesion epicentre. After surgical decompression 19 dogs showed MFR, 14 dogs did not recover. Variance analysis and logistic regressions were calculated between dogs with and without MFR for IMHL and FA values. Sensitivity and specificity were calculated for DPP as dichotomous model. Neither group differences nor prognostic value could be determined for IMHL. FA values measured caudally of the lesion were significantly different between dogs with and without MFR (P = 0.0271). Negative outcome could be predicted using FA with a 62.5% sensitivity, 63.16% specificity, applying cut-off value set at FA > 0.714, whereas DPP revealed 62.5% sensitivity and 73,68% specificity.
COMPARISON OF PRE-OPERATIVE QUANTITATIVE MRI
In conclusion, pre-operative quantitative MRI displayed no advantage over DPP testing concerning MFR in paraplegic dogs. The three-column theory was developed in human medicine to assess the presence of vertebral instability by imaging and assist in the selection of treatment, with biomechanical studies that demonstrate its applicability in humans. Despite the anatomical and postural differences between humans and dogs, this theory has been applied in veterinary medicine for 26 years, without biomechanical studies in dogs.
EX-VIVO
The objective of this study was to evaluate the applicability of three-column theory in thoracolumbar fractures in dogs. Local ethical permission was obtained for this study. Eighteen intact thoracolumbar segments (T12-L2) were collected from dogs that had died for reasons unrelated to this study, and then T12 and L2 vertebrae were fixed in a resin base. After that, they were subjected to computed tomography (CT) scanning to detect any fractures or injuries that had not been diagnosed previously. The range of motion (ROM) parameters of flexion-extension and lateral bending was measured with a goniometer before trauma. Fractures were induced using a powered machine applying compressive loads; after the fracture induction, CT scanning was used to classify the test units according to fractures affecting one, two, or three columns. ROM parameters of all specimens were measured again, and statistically compared.
Results showed that specimens that had a fracture in only one column had no statistical difference in ROM in any of the axis, while the specimens that had fractures in two or three columns showed instability in both axis, concluding this way that the threecolumn concept can be applied to thoracolumbar segment fracture in dogs.
REMOTE ISCHEMIC POSTCONDITIONING IN DOGS
UNDERGOING ELECTIVE SPINAL CORD DECOMPRES-SIVE SURGERY. V. Mortera, N. Granger. University of Bristol, The School of Veterinary Science, Bristol, UK Ischemia-reperfusion injury is a common pathological mechanism in chronic compressive myelopathies. It contributes to neurological deterioration after spinal cord surgical decompression, which can be severe, resulting in prolonged hospitalisation, cost and complications.
Remote-ischemic postconditioning (RIPC) consists of eliciting temporal ischemia-reperfusion in a chosen body part to protect distant organs against the consequences of an anticipated episode of ischemia-reperfusion injury. It is effective for spinal cord protection in laboratory animals. A primary concern for companion animals is to ensure safety of the technique.
We applied RIPC to one forelimb (three cycles of 5-minutes ischemia-reperfusion) in ten dogs with chronic cord compression (7 sub-arachnoid cysts, 3 intervertebral disc protrusion) during anaesthesia and before the start of elective decompressive surgery. Seven dogs deteriorated neurologically postoperatively. No adverse effects were observed during RIPC and for 48 h after surgery. During RIPC, the heart rate increased up to a maximum of 15 heart beats per minutes and the mean arterial blood pressure increased up to a maximum of 20 mmHg from pre-RICP baseline values. Serum potassium, lactate and blood gases remained within normal limits and we collected pre, intra and postoperative serum to measure S100b and neuron specific enolase as biomarkers of neuronal damage. Thromboelastography showed a reduction in maximal amplitude and G-value (clot strength) after RIPC, however no dog showed post-operative vascular complication.
RIPC was safe and easy to perform in the studied dogs. These preliminary results allow us to progress to a randomised trial looking at RIPC benefits for dogs with chronic cervical myelopathy. Whereas intervertebral disc herniation (IVDH) is considered a frequently occurring diagnosis in dogs, clinical signs and outcome of chronic IVDH with spinal cord compression in coatis (Nasua nasua) are unknown.
The purpose of this case report is the description of successful surgical treatment of chronic IVDH despite challenging circumstances of postoperative care in zoo animals. Two male, middle-aged coatis were presented with mild chronic progressive paraparesis. MRI revealed moderate to severe ventral spinal cord compression due to herniated disc material between the first and second lumbar vertebrae, resp. the twelfth and thirteenth thoracic vertebrae. Treatment included mini-hemilaminectomy and partial corpectomy in one animal, in the other one dorsal laminectomy. The spinal cord was bluish, compressed and deviated. After surgery, both coatis were isolated from the group, objects for climbing were removed from the cage to grant restricted mobility. Follow-up was achieved via personal visits and video-observation. Both coatis were ambulatory the day after surgery and showed continuous slow improvement of neurological status. Both coatis are again presented to the public, one has a completely normal gait 6 months after surgery while the second shows low carriage of the tail. In conclusion, surgical treatment followed by restricted mobility seems to be a useful treatment in chronic IVDH in coatis. The objective of this retrospective study was to identify specific features of cervical IVDH in French Bulldogs.
CERVICAL INTERVERTEBRAL DISC EXTRUSIONS IN
Fifty French Bulldogs with surgically confirmed cervical IVDH, managed at our hospital from 2004 to 2016, were selected. Cervical IVDH were 26% of all IVDH (192) in this breed. Thirty-one dogs were males (62%). Mean age at presentation was 4.9 years, and mean weight was 13.1 kg. Patients were grouped according to the severity of neurological deficits: 28 dogs (56%) with neck pain as only clinical sign, 10 dogs (20%) with ambulatory tetraparesis, and 12 dogs (24%) with non-ambulatory tetraparesis. Mean duration of clinical signs before presentation was 9.9 days. Time from surgery to greatest neurological improvement after surgery (recovery time) was 18, 19.2 and 46.5 days for each group, respectively. The most commonly affected disc space was C3-C4 (31 dogs, 62%), followed by C2-C3 and C4-C5 (7 dogs each, 12%). Neck pain as sole clinical sign was the most frequent sign.
The results suggest that C3-C4 is the most commonly herniated cervical disc in French Bulldogs, and this differs from affected discs in others chondrodystropic breeds such as Beagles or Dachshunds (C2-C3). French Bulldogs appear to develop IVDH at younger age (4.9 years old) than these other breeds, to have a higher male predisposition and longer recovery time, and cervical IVDH seems to have a higher prevalence in our study population than in others previously described. Although thoracic hemivertebra with kyphoscoliosis is often considered an incidental finding in brachycephalic breeds, it has been suggested to interfere with spinal biomechanics and intervertebral disc degeneration. Our aim was to evaluate if the occurrence of kyphoscoliosis was associated with a higher prevalence of cervical or thoracolumbar intervertebral disc extrusion (IVDE) in French Bulldogs (FB). FB that underwent computed tomography for reasons unrelated to spinal disease (n = 70), FB with cervical IVDE (n = 24), and FB with thoracolumbar IVDE (n = 35) were included. Signalment, occurrence, number and anatomical location of hemivertebra, spinal kyphosis, scoliosis, and, if relevant, location of IVDE were recorded. Imaging studies were evaluated by two authors, after which a consensus opinion was reached.
There was no significant association between the presence of kyphosis, scoliosis, or hemivertebrae and the occurrence of thoracolumbar or cervical IVDE. There was no significant association between the occurrence of kyphosis, scoliosis, or hemivertebrae and the age of dogs with cervical or thoracolumbar IVDE. There was a significant association between the presence of kyphosis and the anatomical location of thoracolumbar IVDE (P = 0.036). Dogs with kyphosis were more likely to have caudal lumbar IVDEs (L2-L6) compared to FB without kyphosis. There was no association between the presence of scoliosis and the location of the affected disc.
The results of this study do not support the hypothesis that vertebral malformations in French Bulldogs increase the risk of cervical or thoracolumbar IVDE. In agreement with previous findings, dogs with kyphosis are more likely to have a caudal lumbar IVDE. Congenital vertebral malformations (CVM) are relatively common in the thoracic vertebrae of brachycephalic dogs. They can lead to kyphosis of the vertebral column and secondary neurological deficits. The purpose of this retrospective study was to compare the accuracy of radiography and computed tomography (CT) for detection of CVM's.
COMPARISON OF THE ACCURACY OF RADIOGRAPHY
Brachycephalic dogs, which had both radiographs and CT of the thoracic vertebral column performed for a variety of reasons, were retrospectively reviewed by three observers, which classified each thoracic vertebra into normal or abnormal. This process was performed with lateral radiographs alone, with both lateral and ventro-dorsal views, and CT independently. One observer reviewed the images again two weeks later. The intra and inter-observer agreement was calculated.
A total of 630 vertebrae in 49 dogs were reviewed. All observers identified more affected vertebrae when evaluating lateral and ventro-dorsal radiographic views compared to lateral views alone (P < 0.05); and more with CT when compared to lateral and ventro-dorsal radiographic (statistically significant in two observers). Intra-observer agreement in diagnosing absence/presence of malformations for all three techniques was very good (j: 0.91). Interobserver agreement varied from moderate (j: 0.588) to good (j: 0.755).
Approximately 60% of dogs had more than one affected vertebra and the number of dogs identified with no CVM's was not significantly different between the two comparisons described above.
A hereditary component for the development of CVM's has been suggested and CT seems to be an accurate imaging screening modality for selective breeding. MR images of 50 dogs with and 17 dogs without clinical signs of DLSS were retrospectively evaluated for presence of abnormalities in size and signal behaviour of cauda equina nerve roots. Three evaluators used sagittal and transverse T2-weighted images to independently score the subjective increase in size and signal changes of L7-and S1-roots. The findings were correlated with the presence of foraminal and/or central stenosis. Interobserver agreement for nerve root changes was assessed with Cohen's kappa (paired comparison).
RESULTS OF NON-SURGICAL TREATMENT FOR CON-
A total of 268 nerve roots were examined: 20% were enlarged (L7: 69%; S1: 31%) and 16% were hyperintense (L7: 72%, S1: 28%). No enlarged nerve roots were found in control cases. Foraminal stenosis was present in 64/134 foramina, and central stenosis was found in 33/67 cases. Association between enlarged nerve roots and foraminal/central stenosis was significant. Interobserver agreement was fair (0.41 to 0.6) to good (0.61 to 0.8) for both criteria, increase in size and hyperintensity.
In conclusion, L7 and S1 nerve root changes occur frequently in dogs with DLSS and support the clinical diagnosis. The Royal Veterinary College, University of London, Hatfield, UK German Shepherd Dogs (GSDs) are predisposed for lumbosacral disease. Previous research, evaluating dogs presented at a referral institution, suggested medical management of LS disease was associated with a fair prognosis. This study evaluates clinical management of LS pain in GSDs in first-opinion practice.
CLINICAL PRESENTATION AND MANAGEMENT OF GER-
Data on GSDs with confirmed lumbosacral pain was extracted from the VetCompass database of primary-care veterinary clinical records in the UK. Of 85 GSD identified, 60.0% were female, and 68.5% were neutered. The median age at diagnosis was 8.3 years. Concurrent hip pain was shown in 57.7% of cases. Of the 44.7% of dogs that underwent neurological examination, 31.8% had proprioceptive deficits. Incontinence was recorded in 10.6% of dogs. 4.7% dogs were referred to a referral hospital. Radiographs were performed in 25.9% of cases. Analgesia was given to 95.3% of dogs. Non-steroidal-anti-inflammatory-drugs were given to 84.7% of dogs. The most used analgesic protocols were NSAIDS alone (50.6%), opioids and NSAIDS (17.7%) and glucocorticoids and NSAIDS (11.8%). Rest was advised in 23.5% of cases. The vet or owner noted improvement in 64.7% of cases.
During the study period, 44.7% of the dogs died with 34.2% of these deaths being ascribed to lumbosacral pain.
Although this study had limitations in diagnostic accuracy, it overcame selection biases from those dogs that are referred for their condition. This study shows very low numbers of dogs are referred, therefore allowing a different population of dogs with lumbosacral pain to be evaluated. Spinal dysraphism (SD) is an abnormal condition characterized by a variety of structural and functional anomalies of the spinal cord, due to a defect in closure of neural tube and malformative lesions of spinal cord structures, mostly in lower thoracic and lumbosacral regions. SD has been mostly described in Weimaraners and a hereditary basis has been identified.
MAGNETIC RESONANCE IMAGING FINDINGS OF SPINAL
Characteristic clinical signs are observed by 4-6 weeks of age and include postural abnormalities, simultaneous hind limb gait (bunny hopping), ataxia and paresis, bilateral synchronous withdrawal reflex in the hind limbs.
A 1.5 year old male Weimaraner was presented with a history of non progressive gait abnormalities. Neurological exam revealed hind limbs ataxia and mild paresis, bunny hopping and simultaneous bilateral flexor reflex of both hind limbs.
Spinal magnetic resonance (MR) showed a well defined T2-WI and STIR linear hyperintensity, iso-hypointense in T1-WI, extending on the dorsal spinal cord midline from T9 to L1. On transverse images, this midline T2-WI hyperintense area expanded from dorsal to central parts of the spinal cord, with supposed direct connection with the dorsal subarachnoid space. As a consequence of these alterations, the spinal cord appeared almost heart shaped. No abnormal gadolinium enhancement was observed.
These MR findings were considered suggestive of a neural tube defect such as partial duplication of the spinal cord (hemidydemia), diastematomyelia, spinal cord midline cavitations (siringomyelia) or other aberrations possibly associated with abnormal cerebrospinal fluid distribution.
To author's knowledge MR findings of spinal dysraphism have not been previously described in dogs. A 2 year-old male neutered mixed breed dog presented with a soft tanged subcutaneous mass dorsal to the spinous processes of T11/12, which was tender on palpation. Furthermore proprioceptive ataxia of the hind limbs was noted upon clinical workup. On magnetic resonance imaging (MRI) the spinous process of T11 presented a sagittal split intersected by epidural and epaxial soft tissue. A thin T2-hypointense band could be traced from the skin surface to the dura through the split spinous process of T11. The dural tube was focally lifted towards this T2-hypointense band. Level with the disc space T11/T12 severe dilation of the subarachnoid space was noted. At T12 the spinal cord was U-shaped with a dorsal split and then completely bipartite into two cords at T11. From T6 to T8 the central canal presented marked widening. The MRI findings were consistent with a spina bifida with a lipomeningomyelocele and diplomyelia. Surgery was performed to remove the lipomeningomyelocele via hemilaminectomy. On necropsy and patho-histology connective and fatty tissue with vessel sections were found.
The MRI findings as well as the patho-histological results in this report are compatible with a spina bifida with a lipomeningomyelocele and diplomyelia in the caudal thoracic spine. To the author's knowledge this is the first case-report of a lipomeningomyelocele associated with diplomyelia in a dog. In humans, surgical treatment of drug resistant epilepsy ('epilepsy surgery') reduces the seizure frequency with a good prognostic outcome. Knowledge of epileptogenic zones, especially in focal cortical malformations are essential for the successful resection of an epileptogenic focus. Structural and functional magnetic resonance imaging (MRI) support the focus determination but, unfortunately, diagnostic capability is limited by missing brain references. Computational neuroscience may overcome the limitation with the help of population-averaged reference space (template). The techniques allow for comparison across individuals including quantification of anatomical features. Here we present an atlas of the canine brain that may be suited for this purpose.
T2-weighted MRI data (3 T Siemens and 1 T Gyroscan Intera Phillips) of 37 dogs without structural or cerebral-functional lesions were used. Statistical Parametric Mapping (SPM8, UK) and Matlab (Mathworks, UK) were used for the co-registration of canine neuroimages. This includes manual (by using F is ImageJ, FIJI, Germany) and automatic 'unified' segmentation procedure of SPM to retrieve grey (GM) and white (WM) matter as well as cerebrospinal fluid (CSF).
The established template showed detailed and precise defined GM, WM just as CSF. Cerebral gyri and sulci are highly contrasted and exactly described. Consequently, our framework provides an automatically neuroimage processing of clinical canine MRI data for brain tissue analysis. Further work will include more decided templates and a priori tissue information in respect to the morphologically variance of different breeds. This includes a spatial canine brain model with labelled areas to allow further analyses of cortical structures. Contrary to veterinary patients, humans with drug-resistant epilepsy might be considered for epilepsy surgery. Advanced neuroimaging techniques such as magnetic resonance imaging (MRI) are routinely used to help localize the surgically resectable epileptogenic area successfully in some patients. However, this approach often fails and new methods need to be developed. Recently, functional MRI (fMRI) has been used alone or in combination with electroencephalography (EEG) to obtain maps of cerebral activity during ictal and interictal phases, thereby providing a possible avenue for improved localization of the brain areas directly responsible for epileptic seizures.
APPLICATION OF
In our project, seven patients with drug-resistant epilepsy were studied. Simultaneous EEG-fMRI was performed to map the specific brain networks involved during seizures, which were divided into a series of phases: ictal onset, ictal established and late ictal. Statistical parametric mapping (SPM) was then used to generate haemodynamic maps which were analyzed using a new atlas to measure the levels of involvement of ten normal functional brain networks. Similarities in brain activation during seizures across patients were found, and the level of involvement of the networks varied across ictal phases.
In conclusion, we have measured the relationship between ictal activity and brain networks involved in normal brain activity, opening the way to a more quantitative approach to the study of ictal semiology. To consider this in veterinary medicine, similar neuroimaging methods should be recruited and developed. The increasing use of EEG in veterinary patients might be a steppingstone for the introduction of further neuroimaging techniques, which could actually form the base of epilepsy surgery in animals. Access to high quality brain tissue is critical for understanding disease pathogenesis and to validate novel pre-mortem biomarkers for neurological disorders. An optimal resource would promote cross-translation between human and veterinary neurologists, through comparative clinical and molecular phenotyping. Successful human brain banks continue to expand, yet there is no equivalent archive for veterinary patients. We sought to establish the UK's first Companion Animal Brain Bank.
THE EDINBURGH COMPANION ANIMAL BRAIN BANK -
Adapting protocols from the MRC Edinburgh Brain Bank, we have developed standardized methods for archiving brain tissue from animals euthanased on welfare grounds. Samples are collected with informed consent and approval of the R(D)SVS Veterinary Ethical Review Committee. Whole brains are evaluated grossly then bisected to provide fresh-frozen and formalin fixed tissue for matched molecular and histopathological readouts respectively. Fixed hemibrains are processed in transverse section and 31 specified brain regions are embedded.
To date, 30 brains have been banked. 11 of these are derived from animals with non-neurological conditions (designated control tissue). Mean canine fresh brain parameters AE standard error include brain length (rostral tip of the frontal cortex to the caudal tip of cerebellar vermis; 79.0 AE 1.5 mm), brain weight (91.8 AE 3.72 g) and post-mortem interval (28.2 AE 4.7 h). Brain length and weight correlate with r 2 = 0.843. Our protocols optimise sample quality within the logistics of a referral setting and can be reproduced for multi-centre collaborations or for donation to a central bank. Our objective is to create an online searchable database to facilitate tissue requests for ethically-approved research.
BRAINSTEM AUDITORY EVOKED POTENTIALS IN DOGS
WITH IDIOPATHIC PERIPHERAL VESTIBULAR SYN-DROME. T. A. Shaw, F. Liebel, N. Granger, T. R. HarcourtBrown. The School of Veterinary Sciences, University of Bristol, UK Dogs with idiopathic vestibular syndrome can also have involvement of nearby cranial nerves (for instance the facial nerve in idiopathic facial neuropathy). The proximity of the sensory axons transmitting vestibular and auditory information within cranial nerve VIII means that concomitant vestibular and auditory dysfunction is plausible in these dogs, but remains to be investigated. The aim of this study was to evaluate dogs with idiopathic vestibular syndrome for hearing loss and cochlear nerve dysfunction.
In this retrospective study (over 6 years including 12 dogs), we reviewed BAEP traces of dogs diagnosed with idiopathic vestibular syndrome. Wave I-II and I-V interpeak latency (IPL) was compared between the affected side (ipsilateral to the vestibular localisation) and the unaffected contralateral side via a repeated measures t-test.
Nine dogs were diagnosed with idiopathic facial neuropathy and ipsilateral idiopathic vestibular syndrome and three dogs were diagnosed with idiopathic vestibular syndrome only. All dogs were considered to have morphologically normal I, II and V waveforms. Affected/unaffected I-II and I-V IPLs were 0.91 AE 0.049/ 0.90 AE 0.067 ms and 2.72 AE 0.23/0.277 AE 0.26 ms, respectively. The difference between the affected and unaffected side was not statistically significant (I-II IPL: mean difference 0.01583 ms; 95% confidence interval À0.00892, 0.0405; P = 0.187; I-V IPL: mean difference À0.482 ms; 95% confidence interval À0.102, 0.00546; P = 0.927).
The data do not support the hypothesis that dogs with idiopathic vestibular syndrome have cochlear nerve dysfunction, and suggest that all dogs were able to hear. This information could help further characterise canine idiopathic vestibular syndrome and idiopathic cranial polyneuropathies. Facial paralysis is readily recognised in small-animal veterinary practice because of its manifestation of facial asymmetry; the idiopathic form has been previously reported to be present in 75% of dogs. The purpose of this study in dogs was to classify and determine the origin of facial nerve dysfunction using enhanced diagnostic procedures, including magnetic resonance imaging (MRI).
FACIAL NERVE PARALYSIS IN DOGS
The medical records of 69 dogs admitted for facial paralysis were reviewed. Neurological examination confirmed facial nerve abnormalities, which were all investigated with MRI.
Idiopathic facial paralysis was diagnosed in 48% of dogs. Vestibular signs were the most common additional clinical signs and were observed in 36% of dogs with idiopathic facial paralysis.
Peripheral nervous system disease was diagnosed in 19% of dogs, and central nervous system disease occurred in 30% of dogs. Two new predisposed breeds are added, the French bulldog and the Cavalier King Charles spaniel.
Improved diagnostic methods enabled the diagnosis of a higher percentage of inflammatory/infectious diseases, which were absent in the central nervous system aetiologies of a previous similar study, and revealed metabolic (hypothyroidism), inflammatory and neoplastic aetiologies for peripheral nervous system disease.
A prospective trial was performed in dogs with brain gliomas. The cohort was divided into three arms: palliation, radiotherapy alone (RT), RT+temozolomide (RT+TMZ). The RT schedule was ranged between 33 Gy/5 fx and 42 Gy/10 fx. Temozolomide was administered during and after the treatment. Serial clinical and MRI examinations were planned 2, 4, 6, 12, 18, 24 months after irradiation. Overall and disease specific survival time was estimated.
Thirty dogs were palliated, 22 dogs were treated with RT and 20 with RT+TMZ. Complete and partial responses were observed on the whole in 63.2% and 90.9% of alive patients in RT and RT+TMZ arm at 1 year. Median survival in palliation arm was 94 days. Median survival of RT arm (383 days) and RT+TMZ arm (420 days) were not significantly different (P = 0.61). The progression free survival in RT arm (255 days) and RT+TMZ arm (345 days) were significantly different (P = 0.027). The grade of the tumor was not correlated with the survival. The ratio between tumor and brain volume <5% and the clinical presentation with normal mental status were positively correlated with the survival.
VMAT hypo fractionated RT is feasible and effective for canine brain gliomas. The combination with TMZ ameliorate the progression-free survival. A further escalation of TMZ dose trial could be advisable. The neuropeptide somatostatin (SST) plays an important regulatory role in the proliferation of both normal and neoplastic cells. Five subtypes of somatostatin receptors (SSTRs) have been identified in several human tumours, including meningioma. The receptor most commonly identified is the SSTR2a subtype. Long half-life somatostatin analogues (i.e. octreotide) are today included in chemotherapy schedules for unresectable or radiation-refractory recurrent human meningiomas.
SOMASTATIN RECEPTOR (SSTR2) IN CANINE MENIN-
The aim of this study is to test the expression of SSTR2a in canine meningioma by immunohistochemistry and qRT-PCR analyses. Twenty-one FFPE meningiomas were used for IHC investigations performed with rabbit anti-human SSTR2 antibody (1:500, Alomone Labs, Jerusalem, Israel) and avidin-biotin-peroxidase complex method. For each tumour, area of labeling was assessed in five grades, ranging from (-) = absent to (++++) = > 75% of tumour.
Twenty-five meningiomas were also submitted to qRT-PCR investigations performed with Taqman probe (Life Technologies). Total RNA was extracted from 5 μm sections of FFPE tissue with FFPE-RNA Purification Kit (Norgen), and mRNA was reversetranscribed with iScript cDNA synthesis (Bio-rad). At IHC, SSTR2a was expressed in 17/21 cases (81%) showing a diffuse cytoplasmic immunoreaction. The most common histotypes, including meningothelial, fibroblastic, and transitional meningiomas as well as the papillary meningiomas were positive, ranging from (+) to (++++). Grade I, grade II and grade III expressed SSTR2 in 86%, 91%, and 33%, respectively. The PCR-amplification tests gave positive results in the majority of the canine meningiomas. These preliminary results encourage continuing this study aimed to find new chemotherapeutic protocols for dogs.
